FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Verhoef

Research Profile

Living Beings

Physiology

Anatomy

Procedures

Microbial Sensitivity Tests

Chemicals & Drugs

Disorders

Geographic Areas

Concepts & Ideas

Luminescent Measurements

Publications

TOP 3
Alexander L A Bloemendaal; Menno R Vriens; Wouter T M Jansen; Inne H M Borel Rinkes; Jan Verhoef; Ad C Fluit
Colonization and transmission of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in a murine nasal colonization model.
Armand Paauw; Maurine A Leverstein-van Hall; Jan Verhoef; Ad C Fluit
Evolution in quantum leaps: multiple combinatorial transfers of HPI and other genetic modules in Enterobacteriaceae.
A L A Bloemendaal; Ad C Fluit; Wouter Jansen; Menno R Vriens; T Ferry; J M Amorim; Alvaro Pascual; S Stefani; J Papaparaskevas; I H M Borel Rinkes; Jan Verhoef
Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Verhoef (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Alexander L A Bloemendaal; Menno R Vriens; Wouter T M Jansen; Inne H M Borel Rinkes; Jan Verhoef; Ad C Fluit
Colonization and transmission of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in a murine nasal colonization model.
Journal of medical microbiology 2011;60(Pt 6):812-6.
2010: Armand Paauw; Maurine A Leverstein-van Hall; Jan Verhoef; Ad C Fluit
Evolution in quantum leaps: multiple combinatorial transfers of HPI and other genetic modules in Enterobacteriaceae.
PloS one 2010;5(1):e8662.
2009: A L A Bloemendaal; Ad C Fluit; Wouter Jansen; Menno R Vriens; T Ferry; J M Amorim; Alvaro Pascual; S Stefani; J Papaparaskevas; I H M Borel Rinkes; Jan Verhoef
Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2009;30(9):918-20.
2009: Risma Ikawaty; E C Brouwer; Marc D Jansen; E van Duijkeren; Dik J Mevius; Jan Verhoef; Ad C Fluit
Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis.
Veterinary microbiology 2009;136(3-4):277-84.
2009: Armand Paauw; Martien P M Caspers; Maurine A Leverstein-van Hall; Frank H J Schuren; Roy C Montijn; Jan Verhoef; Ad C Fluit
Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain.
Microbiology (Reading, England) 2009;155(Pt 5):1478-88.
2009: Alexander L A Bloemendaal; Ad C Fluit; Wouter Jansen; Menno R Vriens; Tristan Ferry; Laurent Argaud; Jose M Amorim; A C Resende; Alvaro Pascual; Lorena López-Cerero; Stefania Stefani; Giacomo Castiglione; Penelope Evangelopoulou; Sophia Tsiplakou; Inne H M Borel Rinkes; Jan Verhoef
Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2009;30(2):117-24.
2009: Armand Paauw; Maurine A Leverstein-van Hall; Kok P M van Kessel; Jan Verhoef; Ad C Fluit
Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.
PloS one 2009;4(12):e8240.
2009: E C van Asbeck; A I M Hoepelman; J Scharringa; Jan Verhoef
The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis.
International journal of antimicrobial agents 2009;33(1):21-6.
2008: Wouter Jansen; A Verel; MM Beitsma; Jan Verhoef; Dana Milatovic
Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada.
Current medical research and opinion 2008;24(10):2853-61.
2008: Risma Ikawaty; Rob Willems; Adrienne T A Box; Jan Verhoef; Ad C Fluit
Novel multiple-locus variable-number tandem-repeat analysis method for rapid molecular typing of human Staphylococcus aureus.
Journal of clinical microbiology 2008;46(9):3147-51.
2008: Wouter Jansen; A Verel; Jan Verhoef; Dana Milatovic
In vitro activity of AR-709 against Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2008;52(3):1182-3.
2008: Eveline C van Asbeck; Andy I M Hoepelman; Jelle Scharringa; Bjorn L Herpers; Jan Verhoef
Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.
BMC microbiology 2008;8():229.
2008: Armand Paauw; Martien P M Caspers; Frank H J Schuren; Maurine A Leverstein-van Hall; Alexis Delétoile; Roy C Montijn; Jan Verhoef; Ad C Fluit
Genomic diversity within the Enterobacter cloacae complex.
PloS one 2008;3(8):e3018.
2008: Ben U Ridwan; C J M Koning; Marc G H Besselink; Harro M Timmerman; Ellen C Brouwer; Jan Verhoef; Hein G Gooszen; L M A Akkermans
Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis.
Letters in applied microbiology 2008;46(1):61-7.
2007: Wouter Jansen; A Verel; Jan Verhoef; Dana Milatovic
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Antimicrobial agents and chemotherapy 2007;51(9):3420-4.
2007: Bart J M Vlaminckx; Frank H J Schuren; Roy C Montijn; Martien P M Caspers; MM Beitsma; W J B Wannet; Leo M Schouls; Jan Verhoef; Wouter Jansen
Dynamics in prophage content of invasive and noninvasive M1 and M28 Streptococcus pyogenes isolates in The Netherlands from 1959 to 1996.
Infection and immunity 2007;75(7):3673-9.
2007: Miquel B Ekkelenkamp; Jan Verhoef; Marc J M Bonten
Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(11):1457-9.
2007: Bart J M Vlaminckx; Frank H J Schuren; Roy C Montijn; Martien P M Caspers; Ad C Fluit; W J B Wannet; Leo M Schouls; Jan Verhoef; Wouter Jansen
Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray.
Infection and immunity 2007;75(5):2603-11.
2007: Armand Paauw; Jan Verhoef; Ad C Fluit; Hetty E M Blok; T E M Hopmans; Annet Troelstra; Maurine A Leverstein-van Hall
Failure to control an outbreak of qnrA1-positive multidrug-resistant Enterobacter cloacae infection despite adequate implementation of recommended infection control measures.
Journal of clinical microbiology 2007;45(5):1420-5.
2007: Maryam Amidi; Stefan G Romeijn; Jan Verhoef; Hans E Junginger; Laura Bungener; Anke Huckriede; Daan J A Crommelin; Wim Jiskoot
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Vaccine 2007;25(1):144-53.
2006: Wouter Jansen; A Verel; MM Beitsma; Jan Verhoef; Dana Milatovic
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae.
The Journal of antimicrobial chemotherapy 2006;58(4):873-7.
2006: Wouter Jansen; JT van der Bruggen; Jan Verhoef; Ad C Fluit
Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2006;9(3):123-33.
2006: Wouter Jansen; MM Beitsma; C J Koeman; Willem J B Van Wamel; Jan Verhoef; Ad C Fluit
Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2006;50(6):2072-8.
2006: Armand Paauw; Ad C Fluit; Jan Verhoef; Maurine A Leverstein-van Hall
Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital.
Emerging infectious diseases 2006;12(5):807-12.
2006: Ad C Fluit; JT van der Bruggen; F M Aarestrup; Jan Verhoef; Wouter Jansen
Priorities for antibiotic resistance surveillance in Europe.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(5):410-7.
2006: Jan Verhoef; Ad Fluit
Surveillance uncovers the smoking gun for resistance emergence.
Biochemical pharmacology 2006;71(7):1036-41.
2006: Ellen M Mascini; Annet Troelstra; M Beitsma; Hetty E M Blok; KP Jalink; T E M Hopmans; Ad C Fluit; R J Hene; Rob Willems; Jan Verhoef; Marc J M Bonten
Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(6):739-46.
2006: Maurine A Leverstein-van Hall; Hetty E M Blok; Armand Paauw; Ad C Fluit; Annet Troelstra; Ellen M Mascini; Marc J M Bonten; Jan Verhoef
Extensive hospital-wide spread of a multidrug-resistant enterobacter cloacae clone, with late detection due to a variable antibiogram and frequent patient transfer.
Journal of clinical microbiology 2006;44(2):518-24.
2006: Gunnar I Andriesse; Jan Verhoef
Nosocomial pneumonia : rationalizing the approach to empirical therapy.
Treatments in respiratory medicine 2006;5(1):11-30.
2005: Barbara C Baudner; Jan Verhoef; Marzia M Giuliani; Samuele Peppoloni; Rino Rappuoli; Giuseppe Del Giudice; Hans E Junginger
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.
Journal of drug targeting 2005;13(8-9):489-98.
2005: Joke P M in 't Veen; Mascha P van den Berg; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;61(1-2):27-31.
2005: Olga Borges; Gerrit Borchard; Jan Verhoef; Adriano de Sousa; Hans E Junginger
Preparation of coated nanoparticles for a new mucosal vaccine delivery system.
International journal of pharmaceutics 2005;299(1-2):155-66.
2005: Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.
Journal of clinical microbiology 2005;43(8):4178-82.
2005: Menno R Vriens; Hetty E M Blok; Ada C M Gigengack-Baars; Ellen M Mascini; Chr van der Werken; Jan Verhoef; Annet Troelstra
Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(7):629-33.
2005: Ad C Fluit; Alice Florijn; Jan Verhoef; Dana Milatovic
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003.
The Journal of antimicrobial chemotherapy 2005;56(1):133-8.
2005: Ad C Fluit; Alice Florijn; Jan Verhoef; Dana Milatovic
Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
Antimicrobial agents and chemotherapy 2005;49(4):1636-8.
2005: Henk J van Leeuwen; M Van Der Tol; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.
Clinical and experimental immunology 2005;140(1):65-72.
2005: Miquel B Ekkelenkamp; Micha Hanssen; Shang-Te Danny Hsu; Ad de Jong; Dana Milatovic; Jan Verhoef; Nico A J van Nuland
Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
FEBS letters 2005;579(9):1917-22.
2005: Edoardo Carretto; Daniela Barbarini; Isabel Couto; D De Vitis; Piero Marone; Jan Verhoef; Hermínia de Lencastre; Sylvain Brisse
Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(3):177-84.
2005: Harald J van Loon; Menno R Vriens; Ad C Fluit; Annet Troelstra; Chr van der Werken; Jan Verhoef; Marc J M Bonten
Antibiotic rotation and development of gram-negative antibiotic resistance.
American journal of respiratory and critical care medicine 2005;171(5):480-7.
2005: Adrienne T A Box; Dik J Mevius; Pepijn Schellen; Jan Verhoef; Ad C Fluit
Integrons in Escherichia coli from food-producing animals in The Netherlands.
Microbial drug resistance (Larchmont, N.Y.) 2005;11(1):53-7.
2004: Saskia Nijssen; Alice Florijn; Marc J M Bonten; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
International journal of antimicrobial agents 2004;24(6):585-91.
2004: Dean T Tsukayama; Harald J van Loon; C Cartwright; B Chmielewski; Ad C Fluit; Chr van der Werken; Jan Verhoef
The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
International journal of antimicrobial agents 2004;24(4):339-45.
2004: Sylvain Brisse; T van Himbergen; K Kusters; Jan Verhoef
Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(10):942-5.
2004: Farid A Dorkoosh; Marcel P M Stokkel; Dik Blok; Gerrit Borchard; Morteza Rafiee-Tehrani; Jan Verhoef; Hans E Junginger
Feasibility study on the retention of superporous hydrogel composite polymer in the intestinal tract of man using scintigraphy.
Journal of controlled release : official journal of the Controlled Release Society 2004;99(2):199-206.
2004: S M van der Merwe; Jan Verhoef; J H M Verheijden; Awie F Kotzé; Hans E Junginger
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(2):225-35.
2004: Harald J van Loon; Adrienne T A Box; Jan Verhoef; Ad C Fluit
Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.
International journal of antimicrobial agents 2004;24(2):130-4.
2004: Ad C Fluit; Franz-Josef Schmitz; Jan Verhoef; Dana Milatovic
Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
International journal of antimicrobial agents 2004;24(1):59-66.
2004: Sara Haeggman; Sven Löfdahl; Armand Paauw; Jan Verhoef; Sylvain Brisse
Diversity and evolution of the class A chromosomal beta-lactamase gene in Klebsiella pneumoniae.
Antimicrobial agents and chemotherapy 2004;48(7):2400-8.
2004: Mascha P van den Berg; Jan Verhoef; Stefan G Romeijn; Frans W H M Merkus
Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):131-5.
2004: Bart J M Vlaminckx; wilfrid van pelt; Leo M Schouls; A van Silfhout; C Elzenaar; Ellen M Mascini; Jan Verhoef; J F P Schellekens
Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(6):434-44.
2004: Mascha P van den Berg; Paul Merkus; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.
Pharmaceutical research 2004;21(5):799-802.
2004: Péter Antal-Szalmás; Miriam J J G Poppelier; Andrea Sümegi; Tjomme van der Bruggen; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.
Immunology letters 2004;93(1):11-5.
2004: Helke van Dessel; Lenie Dijkshoorn; Tanny Van Der Reijden; Nancy Bakker; Armand Paauw; Peterhans J Van den Broek; Jan Verhoef; Sylvain Brisse
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals.
Research in microbiology 2004;155(2):105-12.
2004: Ad C Fluit; Franz-Josef Schmitz; Jan Verhoef; Dana Milatovic
In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.
Antimicrobial agents and chemotherapy 2004;48(3):1007-11.
2004: Barbara C Baudner; Maurizio Morandi; Marzia M Giuliani; Jan Verhoef; Hans E Junginger; paolo costantino; Rino Rappuoli; Giuseppe Del Giudice
Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system.
The Journal of infectious diseases 2004;189(5):828-32.
2004: Farid A Dorkoosh; Corine Broekhuizen; Gerrit Borchard; Morteza Rafiee-Tehrani; Jan Verhoef; Hans E Junginger
Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers.
Journal of pharmaceutical sciences 2004;93(3):743-52.
2004: Assadang Polnok; Jan Verhoef; Gerrit Borchard; Narong Sarisuta; Hans E Junginger
In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels.
International journal of pharmaceutics 2004;269(2):303-10.
2004: Daniel Jonas; Bettina Spitzmüller; Franz Daschner; Jan Verhoef; Sylvain Brisse
Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.
Research in microbiology 2004;155(1):17-23.
2004: S M van der Merwe; Jan Verhoef; Awie F Kotzé; Hans E Junginger
N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):85-91.
2004: Assadang Polnok; Gerrit Borchard; Jan Verhoef; Narong Sarisuta; Hans E Junginger
Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):77-83.
2003: Ya Ping Wu; Ran Wei; Jan Verhoef
Real time assay of Aspergillus should be used in SARS patients receiving corticosteroids.
BMJ (Clinical research ed.) 2003;327(7428):1405.
2003: Saskia Nijssen; Marc J M Bonten; Cory Franklin; Jan Verhoef; Andy I M Hoepelman; Robert A Weinstein
Relative risk of physicians and nurses to transmit pathogens in a medical intensive care unit.
Archives of internal medicine 2003;163(22):2785-6.
2003: Ellen M Mascini; KP Jalink; T E M Kamp-Hopmans; Hetty E M Blok; Jan Verhoef; Marc J M Bonten; Annet Troelstra
Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.
Journal of clinical microbiology 2003;41(12):5377-83.
2003: Bart J M Vlaminckx; Ellen M Mascini; J F P Schellekens; Leo M Schouls; Armand Paauw; Ad C Fluit; Rodger Novak; Jan Verhoef; Franz Josef Schmitz
Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants.
Journal of clinical microbiology 2003;41(11):4941-9.
2003: Barbara C Baudner; Marzia M Giuliani; Jan Verhoef; Rino Rappuoli; Hans E Junginger; Giuseppe Del Giudice
The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.
Vaccine 2003;21(25-26):3837-44.
2003: Hetty E M Blok; Annet Troelstra; T E M Kamp-Hopmans; Ada C M Gigengack-Baars; Christina M.J.E, Vandenbroucke-Grauls; Annemarie J L Weersink; Jan Verhoef; Ellen M Mascini
Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(9):679-85.
2003: Mireille van Westreenen; Armand Paauw; Ad C Fluit; Sylvain Brisse; Willemien van Dijk; Jan Verhoef
Occurrence and spread of SHV extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Curacao.
The Journal of antimicrobial chemotherapy 2003;52(3):530-2.
2003: T E M Kamp-Hopmans; Hetty E M Blok; Annet Troelstra; Ada C M Gigengack-Baars; Annemarie J L Weersink; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef; Ellen M Mascini
Surveillance for hospital-acquired infections on surgical wards in a Dutch university hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(8):584-90.
2003: Mascha P van den Berg; Paul Merkus; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.
Journal of drug targeting 2003;11(6):325-31.
2003: Jan Verhoef; A Gillissen
Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime.
International journal of antimicrobial agents 2003;21(6):501-9.
2003: Henk J van Leeuwen; Eric C J M Heezius; Geesje M Dallinga; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
Lipoprotein metabolism in patients with severe sepsis.
Critical care medicine 2003;31(5):1359-66.
2003: Cândida F Pereira; Judith T M L Paridaen; Karla Rutten; Marleen C D G Huigen; Marja van de Bovenkamp; Jeena Middel; Nancy Beerens; Ben Berkhout; Rob Schuurman; Lawrence J Marnett; Jan Verhoef; Hans S L M Nottet
Aspirin-like molecules that inhibit human immunodeficiency virus 1 replication.
Antiviral research 2003;58(3):253-63.
2003: Paul Higgins; A C Fluit; D Milatovic; Jan Verhoef; F-J Schmitz
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa.
International journal of antimicrobial agents 2003;21(5):409-13.
2003: Cândida F Pereira; Judith T M L Paridaen; Marja van de Bovenkamp; Jeena Middel; Jan Verhoef; Hans S L M Nottet
APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
The Journal of antimicrobial chemotherapy 2003;51(5):1181-9.
2003: A C Fluit; A Florijn; Jan Verhoef; F-J Schmitz
High-level gentamicin resistance in Enterococcus faecium and Enterococcus faecalis blood culture isolates from 23 European university hospitals.
International journal of antimicrobial agents 2003;21(4):357-9.
2003: Maurine A Leverstein-van Hall; Hetty E M Blok; A Rogier T Donders; Armand Paauw; Ad C Fluit; Jan Verhoef
Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin.
The Journal of infectious diseases 2003;187(2):251-9.
2003: Kok P M van Kessel; Karin Ellen Veldkamp; Andreas Pesschel; Carla J C de Haas; Jan Verhoef; Jos van Strijp
Tips and tricks from Staphylococcus aureus.
Advances in experimental medicine and biology 2003;531():341-9.
2003: Jan Verhoef
Antibiotic resistance: the pandemic.
Advances in experimental medicine and biology 2003;531():301-13.
2003: D Milatovic; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates.
Antimicrobial agents and chemotherapy 2003;47(1):400-4.
2002: Annet Troelstra; T E M Kamp-Hopmans; F J M Wessels; M A J Bilkert-Mooiman; Jan Verhoef; Ellen M Mascini
[Epidemic of methicillin-resistant Staphylococcus aureus due to the transfer of 2 Dutch burn patients from a hospital outside of the Netherlands; who suffers the consequences?].
Nederlands tijdschrift voor geneeskunde 2002;146(46):2204-7.
2002: Menno R Vriens; Hetty E M Blok; Ad C Fluit; Annet Troelstra; Chr van der Werken; Jan Verhoef
Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(11):782-6.
2002: C L C Wielders; Ad C Fluit; Sylvain Brisse; Jan Verhoef; Franz-Josef Schmitz
mecA gene is widely disseminated in Staphylococcus aureus population.
Journal of clinical microbiology 2002;40(11):3970-5.
2002: Farid A Dorkoosh; Jan Verhoef; Gerrit Borchard; Morteza Rafiee-Tehrani; J H M Verheijden; Hans E Junginger
Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers.
International journal of pharmaceutics 2002;247(1-2):47-55.
2002: Farid A Dorkoosh; Jan Verhoef; J H M Verheijden; Morteza Rafiee-Tehrani; Gerrit Borchard; Hans E Junginger
Peroral absorption of octreotide in pigs formulated in delivery systems on the basis of superporous hydrogel polymers.
Pharmaceutical research 2002;19(10):1532-6.
2002: Maurine A Leverstein-van Hall; Ad C Fluit; Armand Paauw; Adrienne T A Box; Sylvain Brisse; Jan Verhoef
Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.
Journal of clinical microbiology 2002;40(10):3703-11.
2002: Inez M van der Lubben; F A C van Opdorp; M R Hengeveld; Jos J M Onderwater; Henk K Koerten; Jan Verhoef; Gerrit Borchard; Hans E Junginger
Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.
Journal of drug targeting 2002;10(6):449-56.
2002: Menno R Vriens; Ad C Fluit; Annet Troelstra; Jan Verhoef; Chr van der Werken
Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit?
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(9):491-4.
2002: Paul Higgins; A C Fluit; D Hafner; Jan Verhoef; F-J Schmitz
Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates.
The Journal of antimicrobial chemotherapy 2002;50(3):438-40.
2002: Luís C Rey; Bart Wolf; J Luciano B Moreira; Dana Milatovic; Jan Verhoef; Calil Kairalla Farhat
Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil.
International journal of antimicrobial agents 2002;20(2):86-92.
2002: Paul Higgins; A C Fluit; D Milatovic; Jan Verhoef; F-J Schmitz
Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 2002;50(2):299-301.
2002: Dana Milatovic; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.
The Journal of antimicrobial chemotherapy 2002;50(2):293-9.
2002: A C Fluit; F-J Schmitz; Jan Verhoef; D Milatovic
In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
The Journal of antimicrobial chemotherapy 2002;50(2):271-6.
2002: Maurine A Leverstein-van Hall; Armand Paauw; Adrienne T A Box; Hetty E M Blok; Jan Verhoef; Ad C Fluit
Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital.
Journal of clinical microbiology 2002;40(8):3038-40.
2002: Farid A Dorkoosh; Dewi Setyaningsih; Gerrit Borchard; Morteza Rafiee-Tehrani; Jan Verhoef; Hans E Junginger
Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers.
International journal of pharmaceutics 2002;241(1):35-45.
2002: F-J Schmitz; S Schwarz; D Milatovic; Jan Verhoef; A C Fluit
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
The Journal of antimicrobial chemotherapy 2002;50(1):145-8.
2002: Maurine A Leverstein-van Hall; Adrienne T A Box; Hetty E M Blok; Armand Paauw; Ad C Fluit; Jan Verhoef
Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting.
The Journal of infectious diseases 2002;186(1):49-56.
2002: Ad C Fluit; Jan Verhoef; Franz-Josef Schmitz
Antimicrobial resistance among isolates cultured from patients hospitalized with lower respiratory tract infection in Europe.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2002;6(2):144-6.
2002: DJ Beaujean; S Veltkamp; Hetty E M Blok; Ada C M Gigengack-Baars; Chr van der Werken; Jan Verhoef; Annemarie J L Weersink
Comparison of two surveillance methods for detecting nosocomial infections in surgical patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(6):444-8.
2002: H van Dessel; T E M Kamp-Hopmans; Ad C Fluit; Sylvain Brisse; Anne Marie G A de Smet; Lenie Dijkshoorn; Annet Troelstra; Jan Verhoef; Ellen M Mascini
Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit.
The Journal of hospital infection 2002;51(2):89-95.
2002: Hessel A Smits; Annemarie Rijsmus; Joyce H van Loon; Jesse W Y Wat; Jan Verhoef; Leonie A Boven; Hans S L M Nottet
Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes.
Journal of neuroimmunology 2002;127(1-2):160-8.
2002: Sylvain Brisse; Vivian Fussing; Ben Ridwan; Jan Verhoef; Rob Willems
Automated ribotyping of vancomycin-resistant Enterococcus faecium isolates.
Journal of clinical microbiology 2002;40(6):1977-84.
2002: Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; W H F Goessens
Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.
Journal of clinical microbiology 2002;40(5):1743-8.
2002: Mascha P van den Berg; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.
Journal of neuroscience methods 2002;116(1):99-107.
2002: Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.
Journal of clinical microbiology 2002;40(4):1546-8.
2002: Ben Ridwan; Ellen M Mascini; Netty van Der Reijden; Jan Verhoef; Marc J M Bonten
What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?
BMJ (Clinical research ed.) 2002;324(7338):666-8.
2002: Luís C Rey; Bart Wolf; J Luciano B Moreira; Jan Verhoef; Calil Kairalla Farhat
[Nasopharyngeal isolates of S. pneumoniae from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility].
Jornal de pediatria 2002;78(2):105-12.
2002: Alice Florijn; Saskia Nijssen; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(3):241-3.
2002: Farid A Dorkoosh; Gerrit Borchard; Morteza Rafiee-Tehrani; Jan Verhoef; Hans E Junginger
Evaluation of superporous hydrogel (SPH) and SPH composite in porcine intestine ex-vivo: assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;53(2):161-6.
2002: Franz-Josef Schmitz; Jasmina Petridou; Dana Milatovic; Jan Verhoef; Ad C Fluit; Stefan Schwarz
In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status.
The Journal of antimicrobial chemotherapy 2002;49(3):580-2.
2002: Annemarie Borst; Jan Verhoef; Edwin Boel; Ad C Fluit
Clinical evaluation of a NASBA-based assay for detection of Candida spp. in blood and blood cultures.
Clinical laboratory 2002;48(9-10):487-92.
2002: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Jan Verhoef; D Milatovic; Ad C Fluit
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
The Journal of antimicrobial chemotherapy 2002;49(1):220-3.
2001: Franz-Josef Schmitz; Mirella Perdikouli; Andreas Beeck; Jan Verhoef; Ad C Fluit
Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
The Journal of antimicrobial chemotherapy 2001;48(6):935-6.
2001: Inez M van der Lubben; Jan Verhoef; Gerrit Borchard; Hans E Junginger
Chitosan for mucosal vaccination.
Advanced drug delivery reviews 2001;52(2):139-44.
2001: Maya Thanou; Jan Verhoef; Hans E Junginger
Oral drug absorption enhancement by chitosan and its derivatives.
Advanced drug delivery reviews 2001;52(2):117-26.
2001: Franz-Josef Schmitz; Jan Verhoef; D Milatovic; Ad C Fluit
Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(11):827-9.
2001: Maurine A Leverstein-van Hall; Ad C Fluit; Hetty E M Blok; Adrienne T A Box; E D J Peters; Annemarie J L Weersink; Jan Verhoef
Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(11):785-91.
2001: Maya Thanou; Jan Verhoef; M T Nihot; J H M Verheijden; Hans E Junginger
Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P.
Pharmaceutical research 2001;18(11):1638-41.
2001: Franz-Josef Schmitz; Mirella Perdikouli; Andreas Beeck; Jan Verhoef; Ad C Fluit
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates.
International journal of antimicrobial agents 2001;18(5):433-6.
2001: Ellen M Mascini; M Jansze; Leo M Schouls; Jan Verhoef; Hans van Dijk
Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.
International journal of antimicrobial agents 2001;18(4):395-8.
2001: Inez M van der Lubben; Jan Verhoef; Gerrit Borchard; Hans E Junginger
Chitosan and its derivatives in mucosal drug and vaccine delivery.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;14(3):201-7.
2001: Maya Thanou; Jan Verhoef; Hans E Junginger
Chitosan and its derivatives as intestinal absorption enhancers.
Advanced drug delivery reviews 2001;50 Suppl 1():S91-101.
2001: Ad C Fluit; C L Wielders; Jan Verhoef; Franz-Josef Schmitz
Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study.
Journal of clinical microbiology 2001;39(10):3727-32.
2001: Franz-Josef Schmitz; Dieter Hafner; R Geisel; P Follmann; C Kirschke; Jan Verhoef; Karl Köhrer; Ad C Fluit
Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital.
Journal of clinical microbiology 2001;39(10):3724-6.
2001: E D J Peters; Maurine A Leverstein-van Hall; Adrienne T A Box; Jan Verhoef; Ad C Fluit
Novel gene cassettes and integrons.
Antimicrobial agents and chemotherapy 2001;45(10):2961-4.
2001: Ad C Fluit; Jan Verhoef; Franz-Josef Schmitz
Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(9):617-25.
2001: Henk J van Leeuwen; André P Van Beek; Geesje M Dallinga-Thie; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
The role of high density lipoprotein in sepsis.
The Netherlands journal of medicine 2001;59(3):102-10.
2001: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Dieter Hafner; Harold Jagusch; Jan Verhoef; Ad C Fluit
Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy 2001;45(9):2666-7.
2001: Sylvain Brisse; Jan Verhoef; M Tibayrenc
Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages.
International journal for parasitology 2001;31(11):1218-26.
2001: Ad C Fluit; F J Schmitz; Jan Verhoef
Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens.
International journal of antimicrobial agents 2001;18(2):147-60.
2001: Jan Verhoef
Stopping short the spread of methicillin-resistant Staphylococcus aureus.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;165(1):31-2.
2001: Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Jan Verhoef; D Milatovic; Ad C Fluit
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 2001;48(1):148-52.
2001: Maya Thanou; Jan Verhoef; J H M Verheijden; Hans E Junginger
Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.
Pharmaceutical research 2001;18(6):823-8.
2001: Hessel A Smits; A J van Beelen; NM de Vos; A Rijsmus; Tjomme van der Bruggen; Jan Verhoef; Freek Van Muiswinkel; Hans S L M Nottet
Activation of human macrophages by amyloid-beta is attenuated by astrocytes.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(11):6869-76.
2001: C L Wielders; Menno R Vriens; Sylvain Brisse; LA de Graaf-Miltenburg; Annet Troelstra; A Fleer; Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected].
Lancet 2001;357(9269):1674-5.
2001: Michael A Pfaller; J Acar; Ronald Jones; Jan Verhoef; J Turnidge; Helio S Sader
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S156-67.
2001: Ana Gales; Ronald Jones; K R Forward; J Liñares; Helio S Sader; Jan Verhoef
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S104-13.
2001: Sylvain Brisse; Jan Verhoef
Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping.
International journal of systematic and evolutionary microbiology 2001;51(Pt 3):915-24.
2001: Franz-Josef Schmitz; Jasmina Petridou; Nadine Astfalk; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit; Stefan Schwarz
Structural alterations in the translational attenuator of constitutively expressed erm(A) genes in Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2001;45(5):1603-4.
2001: Farid A Dorkoosh; Jan Verhoef; Gerrit Borchard; Morteza Rafiee-Tehrani; Hans E Junginger
Development and characterization of a novel peroral peptide drug delivery system.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(3):307-18.
2001: Cândida F Pereira; Jeena Middel; G Jansen; Jan Verhoef; Hans S L M Nottet
Enhanced expression of fractalkine in HIV-1 associated dementia.
Journal of neuroimmunology 2001;115(1-2):168-75.
2001: Hessel A Smits; NM de Vos; Jesse W Y Wat; Tjomme van der Bruggen; Jan Verhoef; Hans S L M Nottet
Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages.
Journal of neuroimmunology 2001;115(1-2):144-51.
2001: P Merkus; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus; Paul F Schouwenburg
Classification of cilio-inhibiting effects of nasal drugs.
The Laryngoscope 2001;111(4 Pt 1):595-602.
2001: Inez M van der Lubben; Jan Verhoef; A C van Aelst; Gerrit Borchard; Hans E Junginger
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
Biomaterials 2001;22(7):687-94.
2001: Ad C Fluit; F J Schmitz; Jan Verhoef
Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(3):188-91.
2001: Annemarie Borst; Maurine A Leverstein-van Hall; Jan Verhoef; Ad C Fluit
Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA).
Diagnostic microbiology and infectious disease 2001;39(3):155-60.
2001: DJ Beaujean; Hetty E M Blok; Ada C M Gigengack-Baars; T E M Kamp-Hopmans; K Ballemans; Jan Verhoef; Annemarie J L Weersink
Five-year surveillance of patients with communicable diseases nursed in isolation.
The Journal of hospital infection 2001;47(3):210-7.
2001: Wouter Jansen; M Väkeväinen-Anttila; Helena Käyhty; Moon H Nahm; N Bakker; Jan Verhoef; Harm Snippe; AF Verheul
Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.
Clinical and diagnostic laboratory immunology 2001;8(2):245-50.
2001: Mechthild Boos; Susanne Mayer; A Fischer; Karl Köhrer; Sybille Scheuring; P Heisig; Jan Verhoef; Ad C Fluit; Franz-Josef Schmitz
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2001;45(3):938-42.
2001: Wouter Jansen; S Hogenboom; MJ Thijssen; Johannis P Kamerling; Johannes Vliegenthart; Jan Verhoef; Harm Snippe; AF Verheul
Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Infection and immunity 2001;69(2):787-93.
2001: F J Schmitz; A Krey; R Sadurski; Jan Verhoef; D Milatovic; A C Fluit
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates.
The Journal of antimicrobial chemotherapy 2001;47(2):239-40.
2001: Bart Wolf; Luís C Rey; L B Moreira; Dana Milatovic; A Fleer; Jan Verhoef; JJ Roord
Carriage of gram-negative bacilli in young Brazilian children with community-acquired pneumonia.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2001;5(3):155-9.
2001: Inez M van der Lubben; F A Konings; Gerrit Borchard; Jan Verhoef; Hans E Junginger
In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.
Journal of drug targeting 2001;9(1):39-47.
2001: Maya Thanou; M T Nihot; M Jansen; Jan Verhoef; Hans E Junginger
Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Journal of pharmaceutical sciences 2001;90(1):38-46.
2000: Péter Antal-Szalmás; Miriam J J G Poppelier; Roel Broekhuizen; Jan Verhoef; Jos van Strijp; Kok P M van Kessel
Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Cytometry 2000;41(4):279-88.
2000: E E Nieuwenhuis; M R Visser; Annemieke Kavelaars; Pieter M Cobelens; A Fleer; W Harmsen; Jan Verhoef; L M Akkermans; Cobi J Heijnen
Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli.
Arthritis and rheumatism 2000;43(11):2583-9.
2000: Bart Wolf; Luís C Rey; Sylvain Brisse; L B Moreira; Dana Milatovic; A Fleer; JJ Roord; Jan Verhoef
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumonia and children attending day-care centres in Fortaleza, Brazil.
The Journal of antimicrobial chemotherapy 2000;46(5):757-65.
2000: Franz-Josef Schmitz; Ad C Fluit; Dieter Hafner; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Sybille Scheuring; Jan Verhoef; Karl Köhrer; C Von Eiff
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates.
Antimicrobial agents and chemotherapy 2000;44(11):3229-31.
2000: Annemarie Borst; Maurine A Leverstein-van Hall; Jan Verhoef; Ad C Fluit
Value of terminal subculture of automated blood cultures in patients with candidaemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(10):803-5.
2000: Bart Wolf; M Kools-Sijmons; Cees M Verduin; Luís C Rey; A Gama; JJ Roord; Jan Verhoef; Alex Van Belkum
Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(10):759-64.
2000: Leonie A Boven; Jeena Middel; E C Breij; D Schotte; Jan Verhoef; C Soderland; Hans S L M Nottet
Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines.
Journal of neurovirology 2000;6(5):382-9.
2000: Sylvain Brisse; D Milatovic; Ad C Fluit; K Kusters; A Toelstra; Jan Verhoef; Franz-Josef Schmitz
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.
Journal of clinical microbiology 2000;38(10):3636-45.
2000: Karin Ellen Veldkamp; H C Heezius; Jan Verhoef; Jos van Strijp; Kok P M van Kessel
Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.
Infection and immunity 2000;68(10):5908-13.
2000: R Bax; N Mullan; Jan Verhoef
The millennium bugs--the need for and development of new antibacterials.
International journal of antimicrobial agents 2000;16(1):51-9.
2000: Cândida F Pereira; Leonie A Boven; Jeena Middel; Jan Verhoef; Hans S L M Nottet
Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions.
Journal of leukocyte biology 2000;68(3):423-8.
2000: Marc J M Bonten; B J Kullberg; R van Dalen; A R Girbes; I M Hoepelman; Willem N Hustinx; J W van der Meer; Peter Speelman; Ellen E Stobberingh; Henri A Verbrugh; Jan Verhoef; J H Zwaveling
Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy.
The Journal of antimicrobial chemotherapy 2000;46(3):351-62.
2000: Carla J C de Haas; Henk J van Leeuwen; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.
Journal of immunological methods 2000;242(1-2):79-89.
2000: DJ Beaujean; Annemarie J L Weersink; Annet Troelstra; Jan Verhoef
A pilot study on infection control in 10 randomly selected European hospitals: results of a questionnaire survey.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2000;21(8):531-4.
2000: Leonie A Boven; Jeena Middel; Jan Verhoef; Christianne J M De Groot; Hans S L M Nottet
Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia.
Neuropathology and applied neurobiology 2000;26(4):356-60.
2000: Franz-Josef Schmitz; Ad C Fluit; D Milatovic; Jan Verhoef; Hans-Peter Heinz; Sylvain Brisse
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2000;46(1):109-13.
2000: Maya Thanou; Jan Verhoef; P Marbach; Hans E Junginger
Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Journal of pharmaceutical sciences 2000;89(7):951-7.
2000: Hessel A Smits; Leonie A Boven; Cândida F Pereira; Jan Verhoef; Hans S L M Nottet
Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia.
European journal of clinical investigation 2000;30(6):526-35.
2000: F J Schmitz; R Sadurski; Jan Verhoef; D Milatovic; A C Fluit
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics.
The Journal of antimicrobial chemotherapy 2000;45(6):921-3.
2000: Franz-Josef Schmitz; R Sadurski; A Kray; Mechthild Boos; R Geisel; Karl Köhrer; Jan Verhoef; Ad C Fluit
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.
The Journal of antimicrobial chemotherapy 2000;45(6):891-4.
2000: Menno R Vriens; Annet Troelstra; E P Yzerman; A M Poth; Jan Verhoef; Chr van der Werken
[Methicillin-resistant Staphylococcus aureus in medical and paramedical personnel returned from work in a foreign hospital].
Nederlands tijdschrift voor geneeskunde 2000;144(19):887-9.
2000: Ad C Fluit; Jan Verhoef; Franz-Josef Schmitz
Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. European SENTRY Participants.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(5):370-4.
2000: Sylvain Brisse; Cees M Verduin; D Milatovic; Ad C Fluit; Jan Verhoef; S Laevens; P Vandamme; Burkhard Tümmler; Henri A Verbrugh; Alex Van Belkum
Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.
Journal of clinical microbiology 2000;38(5):1876-84.
2000: HJ Bootsma; Hans van Dijk; Paul Vauterin; Jan Verhoef; Frits R Mooi
Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.
Molecular microbiology 2000;36(1):93-104.
2000: Carla J C de Haas; E M van Leeuwen; Toon van Bommel; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.
Infection and immunity 2000;68(4):1753-9.
2000: Dana Milatovic; Franz-Josef Schmitz; Sylvain Brisse; Jan Verhoef; Ad C Fluit
In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates.
Antimicrobial agents and chemotherapy 2000;44(4):1102-7.
2000: Ad C Fluit; ME Jones; Franz-Josef Schmitz; J Acar; R Gupta; Jan Verhoef
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(3):454-60.
2000: M E Jones; N M Boenink; Jan Verhoef; Karl Köhrer; Franz-Josef Schmitz
Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment.
The Journal of antimicrobial chemotherapy 2000;45(3):353-6.
2000: Maya Thanou; Awie F Kotzé; T Scharringhausen; HL Luessen; Albertus G de Boer; Jan Verhoef; Hans E Junginger
Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
Journal of controlled release : official journal of the Controlled Release Society 2000;64(1-3):15-25.
2000: Ad C Fluit; M E Jones; F J Schmitz; J Acar; R Gupta; Jan Verhoef
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997.
Antonie van Leeuwenhoek 2000;77(2):147-52.
2000: Ellen M Mascini; M Jansze; J F P Schellekens; J M Musser; J A Faber; L A Verhoef-Verhage; Leo M Schouls; W J van Leeuwen; Jan Verhoef; Hans van Dijk
Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
The Journal of infectious diseases 2000;181(2):631-8.
2000: JM Orendi; Hans S L M Nottet; NM de Vos; M R Visser; Harm Snippe; Charles A B Boucher; Jan Verhoef
Hydroxyurea interferes with antigen-dependent T-cell activation in vitro.
European journal of clinical investigation 2000;30(2):162-6.
2000: Daniel J Diekema; Michael A Pfaller; J Turnidge; Jan Verhoef; J Bell; A C Fluit; G V Doern; Ronald Jones
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.
Microbial drug resistance (Larchmont, N.Y.) 2000;6(3):213-21.
2000: Maya Thanou; Bogdan I Florea; M W Langemeÿer; Jan Verhoef; Hans E Junginger
N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).
Pharmaceutical research 2000;17(1):27-31.
2000: Sylvain Brisse; D Milatovic; Ad C Fluit; Jan Verhoef; Franz-Josef Schmitz
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(1):64-8.
1999: C A Ballemans; Annemarie J L Weersink; Hetty E M Blok; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
Screening for methicillin-resistant Staphylococcus aureus (MRSA): one hour versus twenty-four hours sampling interval.
The Journal of hospital infection 1999;43(4):316-7.
1999: Jan Verhoef; R Gupta
Surveillance of resistance against antimicrobial agents: a European perspective.
The Journal of hospital infection 1999;43 Suppl():S93-6.
1999: F J Schmitz; R Sadurski; A Stattfeld; A Kray; Jan Verhoef; A C Fluit
Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin.
The Journal of antimicrobial chemotherapy 1999;44(6):847-9.
1999: Franz-Josef Schmitz; Ad C Fluit; Sylvain Brisse; Jan Verhoef; Karl Köhrer; D Milatovic
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.
FEMS immunology and medical microbiology 1999;26(3-4):281-7.
1999: Ellen M Mascini; M Jansze; Jan Verhoef; Hans van Dijk
Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B.
Clinical and diagnostic laboratory immunology 1999;6(6):977-80.
1999: Ellen M Mascini; M Jansze; Leo M Schouls; Ad C Fluit; Jan Verhoef; Hans van Dijk
Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and B.
Journal of clinical microbiology 1999;37(11):3469-74.
1999: Hans E Junginger; J A Hoogstraate; Jan Verhoef
Recent advances in buccal drug delivery and absorption--in vitro and in vivo studies.
Journal of controlled release : official journal of the Controlled Release Society 1999;62(1-2):149-59.
1999: M N Widjojoatmodjo; Annemarie Borst; R A Schukkink; A T Box; NM Tacken; B Van Gemen; Jan Verhoef; B Top; Ad C Fluit
Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species.
Journal of microbiological methods 1999;38(1-2):81-90.
1999: Sylvain Brisse; Ad C Fluit; U Wagner; P Heisig; D Milatovic; Jan Verhoef; Sybille Scheuring; Karl Köhrer; Franz-Josef Schmitz
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.
Antimicrobial agents and chemotherapy 1999;43(10):2513-6.
1999: Bart Wolf; A Gama; Luís C Rey; W Fonseca; JJ Roord; A Fleer; Jan Verhoef
Striking differences in the nasopharyngeal flora of healthy Angolan, Brazilian and Dutch children less than 5 years old.
Annals of tropical paediatrics 1999;19(3):287-92.
1999: Michael A Pfaller; Ronald Jones; G V Doern; A C Fluit; Jan Verhoef; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagnostic microbiology and infectious disease 1999;35(1):19-25.
1999: Maya Thanou; Jan Verhoef; Stefan G Romeijn; J Fred Nagelkerke; Frans W H M Merkus; Hans E Junginger
Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea.
International journal of pharmaceutics 1999;185(1):73-82.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group.
International journal of antimicrobial agents 1999;12(4):311-7.
1999: B A Odland; Ronald Jones; Jan Verhoef; A Fluit; Mondell L Beach
Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe).
Diagnostic microbiology and infectious disease 1999;34(4):315-20.
1999: HJ Bootsma; P C Aerts; G Posthuma; Theo Harmsen; Jan Verhoef; Hans van Dijk; Frits R Mooi
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?
Journal of bacteriology 1999;181(16):5090-3.
1999: Sylvain Brisse; D Milatovic; Ad C Fluit; Jan Verhoef; N Martin; Sybille Scheuring; Karl Köhrer; Franz-Josef Schmitz
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins.
Antimicrobial agents and chemotherapy 1999;43(8):2051-5.
1999: Tjomme van der Bruggen; S Nijenhuis; E van Raaij; Jan Verhoef; B Sweder van Asbeck
Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway.
Infection and immunity 1999;67(8):3824-9.
1999: Franz-Josef Schmitz; A Krey; R Geisel; Jan Verhoef; Hans-Peter Heinz; Ad C Fluit
Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):528-30.
1999: Jan Verhoef; DJ Beaujean; Hetty E M Blok; A Baars; A Meyler; Chr van der Werken; Annemarie J L Weersink
A Dutch approach to methicillin-resistant Staphylococcus aureus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):461-6.
1999: DJ Beaujean; Annemarie J L Weersink; Hetty E M Blok; H M Frénay; Jan Verhoef
Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital.
The Journal of hospital infection 1999;42(3):213-8.
1999: Jan Verhoef; J F Acar; R Gupta; R Jones
Surveillance of resistance against antimicrobial agents.
International journal of antimicrobial agents 1999;12(2):77-9.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):450-3.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):414-21.
1999: ME Jones; Franz-Josef Schmitz; Ad C Fluit; J Acar; R Gupta; Jan Verhoef
Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):403-8.
1999: Leonie A Boven; Jeena Middel; P Portegies; Jan Verhoef; G H Jansen; Hans S L M Nottet
Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex.
Journal of neuroimmunology 1999;97(1-2):154-62.
1999: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
The Journal of antimicrobial chemotherapy 1999;43(6):783-92.
1999: Suzanne E Geerlings; Ellen C Brouwer; Wim Gaastra; Jan Verhoef; Andy I M Hoepelman
Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals.
Journal of medical microbiology 1999;48(6):535-9.
1999: Carla J C de Haas; R van der Zee; Barry Benaissa-Trouw; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.
Infection and immunity 1999;67(6):2790-6.
1999: Awie F Kotzé; Maya Thanou; HL Luessen; B G de Boer; Jan Verhoef; Hans E Junginger
Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(3):269-74.
1999: Jan Verhoef; Harm Snippe; Hans S L M Nottet
Christiaan Eijkman. First bacteriologist at Utrecht University, Nobel laureate for his work on vitamins.
Antonie van Leeuwenhoek 1999;75(3):165-9.
1999: Freek Van Muiswinkel; S F Raupp; NM de Vos; Hessel A Smits; Jan Verhoef; Piet Eikelenboom; Hans S L M Nottet
The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.
Journal of neuroimmunology 1999;96(1):121-30.
1999: Leonie A Boven; L Gomes; Christiane Hery; Françoise Gray; Jan Verhoef; P Portegies; Marc Tardieu; Hans S L M Nottet
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4319-27.
1999: Annet Troelstra; LA de Graaf-Miltenburg; Toon van Bommel; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4220-5.
1999: Inge H M van Loo; Han G J van der Heide; N J Nagelkerke; Jan Verhoef; Frits R Mooi
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population.
The Journal of infectious diseases 1999;179(4):915-23.
1999: F J Schmitz; Jan Verhoef; A Fluit
Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. isolates from 20 European university hospitals. SENTRY Participants Group.
The Journal of antimicrobial chemotherapy 1999;43(3):431-4.
1999: P Martinez-Freijo; Ad C Fluit; Franz-Josef Schmitz; Jan Verhoef; M E Jones
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe.
Antimicrobial agents and chemotherapy 1999;43(3):686-9.
1999: Franz-Josef Schmitz; Ad C Fluit; M Gondolf; R Beyrau; E Lindenlauf; Jan Verhoef; Hans-Peter Heinz; ME Jones
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
The Journal of antimicrobial chemotherapy 1999;43(2):253-9.
1999: E Marttin; Jan Verhoef; F Spies; Jan van der Meulen; J Fred Nagelkerke; Henk K Koerten; Frans W H M Merkus
The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies.
Journal of controlled release : official journal of the Controlled Release Society 1999;57(2):205-13.
1999: Awie F Kotzé; Maya Thanou; H L Luebetaen; Albertus G de Boer; Jan Verhoef; Hans E Junginger
Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Journal of pharmaceutical sciences 1999;88(2):253-7.
1999: M E Jones; M R Visser; M Klootwijk; P Heisig; Jan Verhoef; Franz-Josef Schmitz
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Antimicrobial agents and chemotherapy 1999;43(2):421-3.
1999: Ad C Fluit; Franz-Josef Schmitz; ME Jones; J Acar; R Gupta; Jan Verhoef
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 1999;3(3):153-6.
1999: Wilbert M Boek; Stefan G Romeijn; Kees Graamans; Jan Verhoef; Frans W H M Merkus; Egbert H Huizing
Validation of animal experiments on ciliary function in vitro. II. The influence of absorption enhancers, preservatives and physiologic saline.
Acta oto-laryngologica 1999;119(1):98-101.
1999: Wilbert M Boek; Stefan G Romeijn; Kees Graamans; Jan Verhoef; Frans W H M Merkus; Egbert H Huizing
Validation of animal experiments on ciliary function in vitro. I. The influence of substances used clinically.
Acta oto-laryngologica 1999;119(1):93-7.
1999: Awie F Kotzé; HL Luessen; Albertus G de Boer; Jan Verhoef; Hans E Junginger
Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;7(2):145-51.
1998: Franz-Josef Schmitz; Ad C Fluit; M Lückefahr; B Engler; B Hofmann; Jan Verhoef; Hans-Peter Heinz; Ulrich Hadding; ME Jones
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;42(6):807-10.
1998: P Martinez-Freijo; Ad C Fluit; Franz-Josef Schmitz; V S Grek; Jan Verhoef; M E Jones
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.
The Journal of antimicrobial chemotherapy 1998;42(6):689-96.
1998: C H van Nispen; A I Hoepelman; Maja Rozenberg-Arska; Jan Verhoef; Lynn Purkins; SA Willavize
A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.
American journal of surgery 1998;176(6A Suppl):27S-31S.
1998: JM Orendi; A C Bloem; Jan C C Borleffs; F J Wijnholds; NM de Vos; Hans S L M Nottet; M R Visser; Harm Snippe; Jan Verhoef; Charles A B Boucher
Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
The Journal of infectious diseases 1998;178(5):1279-87.
1998: Franz-Josef Schmitz; B Hertel; B Hofmann; Sybille Scheuring; Jan Verhoef; Ad C Fluit; Hans-Peter Heinz; Karl Köhrer; M E Jones
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.
The Journal of antimicrobial chemotherapy 1998;42(4):561-3.
1998: Franz-Josef Schmitz; E Lindenlauf; B Hofmann; Ad C Fluit; Jan Verhoef; Hans-Peter Heinz; ME Jones
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.
The Journal of antimicrobial chemotherapy 1998;42(4):489-95.
1998: Carla J C de Haas; M E van der Tol; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3607-15.
1998: Wouter Jansen; J Gootjes; M Zelle; D V Madore; Jan Verhoef; Harm Snippe; AF Verheul
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Clinical and diagnostic laboratory immunology 1998;5(5):703-10.
1998: W J Van Wamel; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef; Ad C Fluit
The effect of culture conditions on the in-vitro adherence of methicillin-resistant Staphylococcus aureus.
Journal of medical microbiology 1998;47(8):705-9.
1998: Jan Verhoef
[Optimization of the antibiotics policy in the Netherlands. I. The Foundation Task Force for Antibiotics Policy (SWAB)].
Nederlands tijdschrift voor geneeskunde 1998;142(30):1742.
1998: M E Jones; Ronald Jones; Helio S Sader; Jan Verhoef; J Acar
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program.
The Journal of antimicrobial chemotherapy 1998;42(1):119-21.
1998: Franz-Josef Schmitz; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz; ME Jones
Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin.
Journal of medical microbiology 1998;47(6):533-41.
1998: F J Schmitz; Jan Verhoef; H P Heinz; M E Jones
In-vitro activities of quinupristin/dalfopristin and other anti-staphylococcal agents against methicillin-resistant strains of Staphylococcus aureus isolated over a 16-year period.
The Journal of antimicrobial chemotherapy 1998;41(6):662-4.
1998: W J Van Wamel; Gerda S A T van Rossum; Jan Verhoef; Christina M.J.E, Vandenbroucke-Grauls; Ad C Fluit
Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis.
FEMS microbiology letters 1998;163(1):1-9.
1998: Franz-Josef Schmitz; ME Jones; B Hofmann; B Hansen; Sybille Scheuring; M Lückefahr; Ad C Fluit; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz; Karl Köhrer
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.
Antimicrobial agents and chemotherapy 1998;42(5):1249-52.
1998: Franz-Josef Schmitz; Matthias Steiert; B Hofmann; Ad C Fluit; Jan Verhoef; Hans-Peter Heinz; ME Jones
Detection of staphylococcal genes directly from cerebrospinal and peritoneal fluid samples using a multiplex polymerase chain reaction.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(4):272-4.
1998: Franz-Josef Schmitz; B Hofmann; B Hansen; Sybille Scheuring; M Lückefahr; M Klootwijk; Jan Verhoef; Ad C Fluit; Hans-Peter Heinz; Karl Köhrer; ME Jones
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;41(4):481-4.
1998: Franz-Josef Schmitz; Matthias Steiert; HV Tichy; B Hofmann; Jan Verhoef; Hans-Peter Heinz; Karl Köhrer; ME Jones
Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods.
Journal of medical microbiology 1998;47(4):341-51.
1998: Franz-Josef Schmitz; Matthias Steiert; B Hofmann; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz; Karl Köhrer
Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates.
Journal of medical microbiology 1998;47(4):335-40.
1998: F J Schmitz; Jan Verhoef; Helga Idel; Ulrich Hadding; Hans-Peter Heinz; M E Jones
Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital.
The Journal of hospital infection 1998;38(3):237-40.
1998: Franz-Josef Schmitz; Jan Verhoef; Ad C Fluit; Hans-Peter Heinz; M E Jones
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;41(2):311-3.
1998: C J De Haas; NM de Vos; M R Visser; Harm Snippe; Jan Verhoef
Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.
Clinical and experimental immunology 1998;111(2):286-92.
1998: Awie F Kotzé; HL Luessen; B J de Leeuw; Albertus G de Boer; Jan Verhoef; Hans E Junginger
Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Journal of controlled release : official journal of the Controlled Release Society 1998;51(1):35-46.
1998: E Marttin; Jan Verhoef; Frans W H M Merkus
Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Journal of drug targeting 1998;6(1):17-36.
1997: WN Hustinx; Barry Benaissa-Trouw; Kok P M van Kessel; J Kuenen; L Tavares; Kees Kraaijeveld; Jan Verhoef; A Hoepelman
Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
European journal of clinical investigation 1997;27(12):1044-8.
1997: A M Been-Tiktak; Carla J C de Haas; Loek de Graaf; Charles A B Boucher; Jan Verhoef; Jan C C Borleffs; Hans S L M Nottet; Rob Schuurman
In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.
The Journal of antimicrobial chemotherapy 1997;40(6):847-53.
1997: DJ Beaujean; Hetty E M Blok; Annemarie J L Weersink; Jan Verhoef
Long-term methicillin-resistant Staphylococcus aureus (MRSA) carriage and tagging of patient records: in Utrecht you're not MRSA-positive for life.
The Journal of hospital infection 1997;37(4):338-9.
1997: Wendy S Chaka; Robert S Heyderman; I Gangaidzo; Valerie J Robertson; P Mason; Jan Verhoef; AF Verheul; Andy I M Hoepelman
Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group.
The Journal of infectious diseases 1997;176(6):1633-6.
1997: Franz-Josef Schmitz; Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst.
The Journal of infectious diseases 1997;176(6):1531-7.
1997: WN Hustinx; Barry Benaissa-Trouw; T Harmsen; S Klein; Jan Verhoef; A I Hoepelman; K Kraaijeveld
Evaluation of protection by two endotoxin-neutralizing IgM monoclonal antibodies in different peritonitis models.
The Journal of antimicrobial chemotherapy 1997;40(4):567-72.
1997: WN Hustinx; K Kraaijeveld; A I Hoepelman; Jan Verhoef
Cross-protection by anti-core glycolipid antibodies: evidence from animal experiments.
The Journal of antimicrobial chemotherapy 1997;40(4):475-83.
1997: Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Staphylococcal culture supernates stimulate human phagocytes.
Inflammation 1997;21(5):541-51.
1997: Wendy S Chaka; AF Verheul; VV Vaishnav; R Cherniak; Jelle Scharringa; Jan Verhoef; Harm Snippe; Andy I M Hoepelman
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2979-85.
1997: Awie F Kotzé; HL Luessen; B J de Leeuw; B G de Boer; Jan Verhoef; Hans E Junginger
N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Pharmaceutical research 1997;14(9):1197-202.
1997: Franz-Josef Schmitz; Colin R Mackenzie; R Geisel; S Wagner; Helga Idel; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz
Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area.
European journal of epidemiology 1997;13(6):709-17.
1997: Franz-Josef Schmitz; Colin R Mackenzie; R Geisel; S Wagner; Helga Idel; Jan Verhoef; Ulrich Hadding; Hans-Peter Heinz
Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.
European journal of epidemiology 1997;13(6):699-708.
1997: Franz-Josef Schmitz; Colin R Mackenzie; B Hofmann; Jan Verhoef; M Finken-Eigen; Hans-Peter Heinz; Karl Köhrer
Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR.
Journal of medical microbiology 1997;46(9):773-8.
1997: DJ Beaujean; Hetty E M Blok; Christina M.J.E, Vandenbroucke-Grauls; Annemarie J L Weersink; J A Raymakers; Jan Verhoef
Surveillance of nosocomial infections in geriatric patients.
The Journal of hospital infection 1997;36(4):275-84.
1997: E Marttin; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits.
Journal of pharmaceutical sciences 1997;86(7):802-7.
1997: M E Jones; E Peters; A M Weersink; A Fluit; Jan Verhoef
Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria.
Lancet 1997;349(9067):1742-3.
1997: P Antal-Szalmas; J A Strijp; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel
Quantitation of surface CD14 on human monocytes and neutrophils.
Journal of leukocyte biology 1997;61(6):721-8.
1997: Annet Troelstra; P Antal-Szalmas; LA de Graaf-Miltenburg; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
Infection and immunity 1997;65(6):2272-7.
1997: E Marttin; Jan Verhoef; C Cullander; Stefan G Romeijn; J Fred Nagelkerke; Frans W H M Merkus
Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Pharmaceutical research 1997;14(5):631-7.
1997: I W Craane-Van Hinsberg; Jan Verhoef; F Spies; Joke A Bouwstra; Gert S Gooris; Hans E Junginger; Harry E Boddé
Electroperturbation of the human skin barrier in vitro: II. Effects on stratum corneum lipid ordering and ultrastructure.
Microscopy research and technique 1997;37(3):200-13.
1997: Stefan G Romeijn; E Marttin; Jan Verhoef; Frans W H M Merkus
Simplified solid-phase extraction method for determination of dihydroergotamine in rabbit and human serum using high-performance liquid chromatography with fluorescence detection.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(1):227-32.
1997: JM Orendi; AF Verheul; NM de Vos; M R Visser; Harm Snippe; R Cherniak; VV Vaishnav; Ger T Rijkers; Jan Verhoef
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication.
Clinical and experimental immunology 1997;107(2):293-9.
1997: Annet Troelstra; B N Giepmans; Kok P M van Kessel; H S Lichenstein; Jan Verhoef; Jos van Strijp
Dual effects of soluble CD14 on LPS priming of neutrophils.
Journal of leukocyte biology 1997;61(2):173-8.
1997: Ellen M Mascini; M M Hazenberg; A van Dalen; L A Verhoef-Verhage; N J van Leeuwen; Jan Verhoef; Hans van Dijk
Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
Advances in experimental medicine and biology 1997;418():921-2.
1997: M A Bornemann; Jan Verhoef; P K Peterson
Macrophages, cytokines, and HIV.
The Journal of laboratory and clinical medicine 1997;129(1):10-6.
1997: Hans S L M Nottet; I I Moelans; NM de Vos; Loek de Graaf; M R Visser; Jan Verhoef
N-acetyl-L-cysteine-induced up-regulation of HIV-1 gene expression in monocyte-derived macrophages correlates with increased NF-kappaB DNA binding activity.
Journal of leukocyte biology 1997;61(1):33-9.
1997: Wendy S Chaka; AF Verheul; VV Vaishnav; R Cherniak; Jelle Scharringa; Jan Verhoef; Harm Snippe; IM Hoepelman
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.
Infection and immunity 1997;65(1):272-8.
1996: Jan D A Van Embden; D Van Soolingen; H F Heersma; Albert J de Neeling; M E Jones; Matthias Steiert; V Grek; F R Mooi; Jan Verhoef
Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci.
The Journal of antimicrobial chemotherapy 1996;38(5):905-7.
1996: HL Luessen; B J de Leeuw; M W Langemeÿer; A B de Boer; Jan Verhoef; Hans E Junginger
Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Pharmaceutical research 1996;13(11):1668-72.
1996: Ellen M Mascini; M A Hazenberg; L A Verhage; S E Holm; Jan Verhoef; H van Dijk
A new procedure for the purification of streptococcal pyrogenic exotoxin A from Streptococcus pyogenes supernatant.
Clinical and diagnostic laboratory immunology 1996;3(6):779-81.
1996: E Mattsson; H Van Dijk; Jan Verhoef; R Norrby; J Rollof
Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes.
Infection and immunity 1996;64(10):4351-5.
1996: C Hol; C Schalén; C M Verduin; E E Van Dijke; Jan Verhoef; A Fleer; H Van Dijk
Moraxella catarrhalis in acute laryngitis: infection or colonization?
The Journal of infectious diseases 1996;174(3):636-8.
1996: WN Hustinx; Barry Benaissa-Trouw; T Harmsen; Andy I M Hoepelman; I van der Tweel; Jan Verhoef; K A Kraaijeveld
In vivo TNF induction by culture supernatants of antibiotic-treated Escherichia coli 07:K1. Role of antibiotic class and concentration.
International journal of antimicrobial agents 1996;7(3):171-9.
1996: Jan Verhoef; W M Hustinx; H Frasa; A I Hoepelman
Issues in the adjunct therapy of severe sepsis.
The Journal of antimicrobial chemotherapy 1996;38(2):167-82.
1996: A J Hoogstraate; Jan Verhoef; B Tuk; A Pijpers; L A M G van Leengoed; J H Verheijden; Hans E Junginger; Harry E Boddé
In-vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs.
Journal of pharmaceutical sciences 1996;85(5):457-60.
1996: H Frasa; Barry Benaissa-Trouw; L Tavares; Kok P M van Kessel; W Hustinx; J Schellekens; K Kraaijeveld; Jan Verhoef
Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.
Antimicrobial agents and chemotherapy 1996;40(4):999-1004.
1996: H J Bootsma; H van Dijk; Jan Verhoef; A Fleer; Frits R Mooi
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
Antimicrobial agents and chemotherapy 1996;40(4):966-72.
1996: H Frasa; Barry Benaissa-Trouw; L Tavares; Kok P M van Kessel; M Poppelier; K Kraaijeveld; Jan Verhoef
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.
Infection and immunity 1996;64(3):775-81.
1996: H M Frénay; Annelies Bunschoten; Leo M Schouls; W J van Leeuwen; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef; Frits R Mooi
Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(1):60-4.
1996: E Mattsson; H Van Dijk; Kok P M van Kessel; Jan Verhoef; André Fleer; J Rollof
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar.
The Journal of infectious diseases 1996;173(1):212-8.
1995: E AlonsoDeVelasco; AF Verheul; Jan Verhoef; Harm Snippe
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.
Microbiological reviews 1995;59(4):591-603.
1995: Wendy S Chaka; Jelle Scharringa; AF Verheul; Jan Verhoef; A G Van Strijp; IM Hoepelman
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry.
Clinical and diagnostic laboratory immunology 1995;2(6):753-9.
1995: W H Craane-van Hinsberg; Jan Verhoef; L J Bax; Hans E Junginger; Harry E Boddé
Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin.
Pharmaceutical research 1995;12(10):1506-12.
1995: M N Widjojoatmodjo; Ad C Fluit; Jan Verhoef
Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene.
Journal of clinical microbiology 1995;33(10):2601-6.
1995: HL Luessen; Jan Verhoef; G Borchard; Claus-Michael Lehr; Albertus G de Boer; Hans E Junginger
Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin.
Pharmaceutical research 1995;12(9):1293-8.
1995: E Alonso De Velasco; B A Dekker; AF Verheul; R G Feldman; Jan Verhoef; Harm Snippe
Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice.
The Journal of infectious diseases 1995;172(2):562-5.
1995: J C Pikaar; WF Voorhout; Lambert M G van Golde; Jan Verhoef; Jos van Strijp; J F van Iwaarden
Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.
The Journal of infectious diseases 1995;172(2):481-9.
1995: E Marttin; Jan Verhoef; Stefan G Romeijn; Frans W H M Merkus
Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity.
Pharmaceutical research 1995;12(8):1151-7.
1995: W J Van Wamel; Ad C Fluit; T Wadström; H van Dijk; Jan Verhoef; Christina M.J.E, Vandenbroucke-Grauls
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus.
Journal of clinical microbiology 1995;33(7):1769-74.
1995: D A Watson; D M Musher; Jan Verhoef
Pneumococcal virulence factors and host immune responses to them.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1995;14(6):479-90.
1995: C Hol; C M Verduin; E E Van Dijke; Jan Verhoef; A Fleer; H van Dijk
Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.
FEMS immunology and medical microbiology 1995;11(3):207-11.
1995: C M Verduin; C Hol; E Van Dijke; J A Faber; M Jansze; Jan Verhoef; H Van Dijk
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.
Clinical and diagnostic laboratory immunology 1995;2(3):365-8.
1995: Ad C Fluit; M N Widjojoatmodjo; Jan Verhoef
Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR.
Journal of clinical microbiology 1995;33(4):1046-7.
1995: N G Schipper; Jan Verhoef; Stefan G Romeijn; Frans W H M Merkus
Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Calcified tissue international 1995;56(4):280-2.
1995: Jan Verhoef; E Mattsson
The role of cytokines in gram-positive bacterial shock.
Trends in microbiology 1995;3(4):136-40.
1995: E A de Velasco; D Merkus; SM Anderton; AF Verheul; E F Lizzio; Ruurd van der Zee; Willem van Eden; T Hoffman; Jan Verhoef; Harm Snippe
Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
Infection and immunity 1995;63(3):961-8.
1995: C A Benne; CA Kraaijeveld; Jos van Strijp; E Brouwer; M Harmsen; Jan Verhoef; Lambert M G van Golde; J F van Iwaarden
Interactions of surfactant protein A with influenza A viruses: binding and neutralization.
The Journal of infectious diseases 1995;171(2):335-41.
1995: Kok P M van Kessel; Annemarie J L Weersink; M E Van der Tol; Jan Verhoef
Stimulated human neutrophils release intact BPI without a concomitant change in expression on the cell surface.
Progress in clinical and biological research 1995;392():305-15.
1995: C M Vanderbroucke-Grauls; K B Teeuw; K Ballemans; C Lavooij; P B Cornelisse; Jan Verhoef
Bacterial and viral removal efficiency, heat and moisture exchange properties of four filtration devices.
The Journal of hospital infection 1995;29(1):45-56.
1994: Hans S L M Nottet; B Sweder van Asbeck; Loek de Graaf; NM de Vos; Maarten R Visser; Jan Verhoef
Role for oxygen radicals in self-sustained HIV-1 replication in monocyte-derived macrophages: enhanced HIV-1 replication by N-acetyl-L-cysteine.
Journal of leukocyte biology 1994;56(6):702-7.
1994: C Hol; E E Van Dijke; C M Verduin; Jan Verhoef; H van Dijk
Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.
The Journal of infectious diseases 1994;170(6):1613-6.
1994: M N Widjojoatmodjo; Ad C Fluit; Jan Verhoef
Rapid identification of bacteria by PCR-single-strand conformation polymorphism.
Journal of clinical microbiology 1994;32(12):3002-7.
1994: Annemarie J L Weersink; Kok P M van Kessel; M E Van der Tol; Jan Verhoef
Modulation of lipopolysaccharide binding to human granulocytes.
Immunology 1994;83(4):617-23.
1994: E A DeVelasco; H A Dekker; P Antal; K P Jalink; Jos van Strijp; AF Verheul; Jan Verhoef; Harm Snippe
Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.
Vaccine 1994;12(15):1419-22.
1994: M J Wolfhagen; K Meijer; Ad C Fluit; Ruurd Torensma; R A Bruinsma; A Fleer; Jan Verhoef
Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.
Gut 1994;35(11):1608-12.
1994: K B Teeuw; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
Airborne gram-negative bacteria and endotoxin in sick building syndrome. A study in Dutch governmental office buildings.
Archives of internal medicine 1994;154(20):2339-45.
1994: J F Van Iwaarden; J C Pikaar; J Storm; E Brouwer; Jan Verhoef; R S Oosting; Lambert M G van Golde; Jos van Strijp
Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides.
The Biochemical journal 1994;303 ( Pt 2)():407-11.
1994: P M Schneeberger; P van Langevelde; Kok P M van Kessel; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
Lipopolysaccharide induces hyperadhesion of endothelial cells for neutrophils leading to damage.
Shock (Augusta, Ga.) 1994;2(4):296-300.
1994: E Mattsson; J Rollof; Jan Verhoef; H Van Dijk; André Fleer
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors.
Infection and immunity 1994;62(9):3837-43.
1994: W H Craane-van Hinsberg; L Bax; N H Flinterman; Jan Verhoef; Hans E Junginger; Harry E Boddé
Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance.
Pharmaceutical research 1994;11(9):1296-300.
1994: H M Frénay; P G Peerbooms; W J van Leeuwen; H J Wynne; Jan Verhoef; W D Hendriks; H J Cools
Nursing homes: not a source of methicillin-resistant Staphylococcus aureus in The Netherlands.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):213-4.
1994: Ruurd Torensma; Ad C Fluit; Jan Verhoef
Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(1):11-4.
1994: M J Wolfhagen; Ad C Fluit; Ruurd Torensma; M J Poppelier; Jan Verhoef
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay.
Journal of clinical microbiology 1994;32(7):1629-33.
1994: JM Orendi; Hans S L M Nottet; Maarten R Visser; AF Verheul; Harm Snippe; Jan Verhoef
Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumour necrosis factor-independent.
AIDS (London, England) 1994;8(4):423-9.
1994: H M Frénay; J P Theelen; Leo M Schouls; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef; W J van Leeuwen; Frits R Mooi
Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism.
Journal of clinical microbiology 1994;32(3):846-7.
1994: A J Weersink; M Rozenberg-Arska; P W Westerhof; Jan Verhoef
Rothia dentocariosa endocarditis complicated by an abdominal aneurysm.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(3):489-90.
1994: E Alonso de Velasco; AF Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; Johannis P Kamerling; Johannes Vliegenthart; Jan Verhoef; Harm Snippe
Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Infection and immunity 1994;62(3):799-808.
1994: C W H De Fijter; L P Oe; J J Nauta; Jan van der Meulen; Henri A Verbrugh; Jan Verhoef; A J M Donker
Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis.
Annals of internal medicine 1994;120(4):264-71.
1994: C M Verduin; M Jansze; C Hol; T E Mollnes; Jan Verhoef; H van Dijk
Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.
Infection and immunity 1994;62(2):589-95.
1994: Hans S L M Nottet; M H Oteman; Maarten R Visser; Jan Verhoef
Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors.
The Journal of antimicrobial chemotherapy 1994;33(2):366-8.
1994: M J Wolfhagen; Ruurd Torensma; Ad C Fluit; C J Aarsman; M Jansze; Jan Verhoef
Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors.
Toxicon : official journal of the International Society on Toxinology 1994;32(1):129-32.
1994: C W H De Fijter; Henri A Verbrugh; PL Oe; E C Heezius; Jan Verhoef; A J M Donker
Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(2):156-62.
1994: J D Kuenen; E E van Dijke; C Hol; H J Bootsma; Jan Verhoef; H van Dijk
Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice.
FEMS immunology and medical microbiology 1994;8(1):69-75.
1994: N G Schipper; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
Calcified tissue international 1994;54(1):50-5.
1994: M J Wolfhagen; Ruurd Torensma; Ad C Fluit; Jan Verhoef
Toxins A and B of Clostridium difficile.
FEMS microbiology reviews 1994;13(1):59-64.
1994: M Floor; F van Akkeren; Maja Rozenberg-Arska; M Visser; A Kolsters; H Beumer; Jan Verhoef
Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.
Scandinavian journal of infectious diseases 1994;26(2):191-7.
1994: H F Brulez; E C Heezius; C W H De Fijter; L P Oe; Jan Verhoef; Henri A Verbrugh
In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1994;10():241-4.
1994: L A De Graaf-Miltenburg; K E Van Vliet; T L Ten Hagen; Jan Verhoef; Jos van Strijp
The role of HSV-induced Fc- and C3b (i)-receptors in bacterial adherence.
Journal of medical microbiology 1994;40(1):48-54.
1994: B A van de Wiel; L J Bakker; Loek de Graaf; Roel A de Weger; Jan Verhoef; Jan G van den Tweel; P Joling
Complement and antibody enhance binding and uptake of HIV-1 by bone marrow cells.
Advances in experimental medicine and biology 1994;355():159-63.
1994: A J Hoogstraate; C Cullander; J Fred Nagelkerke; S Senel; Jan Verhoef; Hans E Junginger; Harry E Boddé
Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium.
Pharmaceutical research 1994;11(1):83-9.
1993: N G Schipper; Jan Verhoef; L M De Lannoy; Stefan G Romeijn; J H Brakkee; V M Wiegant; W H Gispen; Frans W H M Merkus
Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
British journal of pharmacology 1993;110(4):1335-40.
1993: Jan Verhoef; E A Verhage; M R Visser
A decade of experience with selective decontamination of the digestive tract as prophylaxis for infections in patients in the intensive care unit: what have we learned?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(6):1047-54.
1993: M van der Feltz; Hans S L M Nottet; Maarten R Visser; J C Borleffs; Jan Verhoef
Non-radioactive PCR method for quantification of HIV-infected peripheral blood mononuclear cells in HIV-positive subjects.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(12):961-4.
1993: H Frasa; J Procee; Ruurd Torensma; A Verbruggen; Ale Algra; M Rozenberg-Arska; K Kraaijeveld; Jan Verhoef
Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.
Journal of clinical microbiology 1993;31(12):3174-8.
1993: E Alonso de Velasco; AF Verheul; G H Veeneman; L J Gomes; J H van Boom; Jan Verhoef; Harm Snippe
Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
Vaccine 1993;11(14):1429-36.
1993: David Watson; Daniel M Musher; J W Jacobson; Jan Verhoef
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(5):913-24.
1993: Jan Verhoef
Prevention of infections in the neutropenic patient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17 Suppl 2():S359-67.
1993: Andy I M Hoepelman; H Kieft; M Aoun; J Kosmidis; T Strand; Jan Verhoef; S H Gillespie; J Riddell; G Varghese; F Meunier
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
The Journal of antimicrobial chemotherapy 1993;32 Suppl B():175-86.
1993: H Kieft; Andy I M Hoepelman; C A Knupp; A van Dijk; J M Branger; A Struyvenberg; Jan Verhoef
Pharmacokinetics of cefepime in patients with the sepsis syndrome.
The Journal of antimicrobial chemotherapy 1993;32 Suppl B():117-22.
1993: H Kieft; Andy I M Hoepelman; W Zhou; Maja Rozenberg-Arska; A Struyvenberg; Jan Verhoef
The sepsis syndrome in a Dutch university hospital. Clinical observations.
Archives of internal medicine 1993;153(19):2241-7.
1993: C P Timmerman; E Mattsson; L Martinez-Martinez; Loek de Graaf; Jos van Strijp; Henri A Verbrugh; Jan Verhoef; André Fleer
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.
Infection and immunity 1993;61(10):4167-72.
1993: E Mattsson; L Verhage; J Rollof; André Fleer; Jan Verhoef; H van Dijk
Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6.
FEMS immunology and medical microbiology 1993;7(3):281-7.
1993: M N Widjojoatmodjo; Ad C Fluit; Ruurd Torensma; Jan Verhoef
Comparison of immunomagnetic beads coated with protein A, protein G, or goat anti-mouse immunoglobulins. Applications in enzyme immunoassays and immunomagnetic separations.
Journal of immunological methods 1993;165(1):11-9.
1993: L Martínez-Martínez; C P Timmerman; André Fleer; Jan Verhoef
Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis.
Journal of medical microbiology 1993;39(3):196-203.
1993: GM Raponi; N Keller; M Rozenberg-Arska; M T Lun; Carlo Mancini; Jan Verhoef
Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity.
Infection and immunity 1993;61(9):3976-80.
1993: I Corrales; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel
Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
Immunology 1993;80(1):84-9.
1993: J J Cornelissen; K Maassen; L van Emst; P M Weers; M Harmsen; Barry Benaissa-Trouw; T A Oosterlaken; CA Kraaijeveld; Jan Verhoef
Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Immunology 1993;79(4):673-80.
1993: Ruurd Torensma; M J Visser; C J Aarsman; M J Poppelier; Ad C Fluit; Jan Verhoef
Monoclonal antibodies that react with live Listeria spp.
Applied and environmental microbiology 1993;59(8):2713-6.
1993: M J Wolfhagen; Ad C Fluit; Ruurd Torensma; M Jansze; A F Kuypers; E A Verhage; Jan Verhoef
Comparison of typing methods for Clostridium difficile isolates.
Journal of clinical microbiology 1993;31(8):2208-11.
1993: Hans S L M Nottet; Loek de Graaf; NM de Vos; L J Bakker; Jos van Strijp; Maarten R Visser; Jan Verhoef
Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1993;168(1):84-91.
1993: K B Teeuw; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
[Microorganisms in the air and the sick-building syndrome].
Nederlands tijdschrift voor geneeskunde 1993;137(23):1132-5.
1993: Andy I M Hoepelman; A P Sips; J L van Helmond; P W van Barneveld; A J Neve; M Zwinkels; Maja Rozenberg-Arska; Jan Verhoef
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 1993;31 Suppl E():147-52.
1993: M J Wolfhagen; Ad C Fluit; M Jansze; Carin M A Rademaker; Jan Verhoef
Detection of toxigenic Clostridium difficile in fecal samples by colony blot hybridization.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(6):463-6.
1993: C Hol; C M Verduin; E van Dijke; Jan Verhoef; H van Dijk
Complement resistance in Branhamella (Moraxella) catarrhalis.
Lancet 1993;341(8855):1281.
1993: Ad C Fluit; M N Widjojoatmodjo; A T Box; Ruurd Torensma; Jan Verhoef
Rapid detection of salmonellae in poultry with the magnetic immuno-polymerase chain reaction assay.
Applied and environmental microbiology 1993;59(5):1342-6.
1993: Ad C Fluit; Ruurd Torensma; M J Visser; C J Aarsman; M J Poppelier; B H Keller; P Klapwijk; Jan Verhoef
Detection of Listeria monocytogenes in cheese with the magnetic immuno-polymerase chain reaction assay.
Applied and environmental microbiology 1993;59(5):1289-93.
1993: Hans S L M Nottet; I Janse; Loek de Graaf; L J Bakker; Maarten R Visser; Jan Verhoef
Infection of epithelial cell line HEp-2 with human immunodeficiency virus type 1 is CD4 dependent.
Journal of medical virology 1993;40(1):39-43.
1993: Ilja M Hoepelman; W H Havinga; R A Benne; M Zwinkels; M A de Wit; H A de Hond; T A Boon; Maarten R Visser; F W van Asbeck; Jan Verhoef
Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(5):343-7.
1993: N G Schipper; Stefan G Romeijn; Jan Verhoef; Frans W H M Merkus
Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Pharmaceutical research 1993;10(5):682-6.
1993: C W H De Fijter; Henri A Verbrugh; L P Oe; E Heezius; A J M Donker; Jan Verhoef; R Gokal
Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;21(4):411-8.
1993: J J Cornelissen; I Mäkel; Ale Algra; Barry Benaissa-Trouw; J F Schellekens; CA Kraaijeveld; Jan Verhoef
Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.
The Journal of infectious diseases 1993;167(4):876-81.
1993: Hans S L M Nottet; Loek de Graaf; N Machiel de Vos; L J Bakker; Jos van Strijp; Maarten R Visser; Jan Verhoef
Down-regulation of human immunodeficiency virus type (HIV-1) production after stimulation of monocyte-derived macrophages infected with HIV-1.
The Journal of infectious diseases 1993;167(4):810-7.
1993: Maarten R Visser; H Beumer; Andy I M Hoepelman; Maja Rozenberg-Arska; Jan Verhoef
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Antimicrobial agents and chemotherapy 1993;37(4):885-8.
1993: Christina M.J.E, Vandenbroucke-Grauls; A C Baars; Maarten R Visser; PF Hulstaert; Jan Verhoef
An outbreak of Serratia marcescens traced to a contaminated bronchoscope.
The Journal of hospital infection 1993;23(4):263-70.
1993: Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
[A new chapter in the history of tuberculosis].
Nederlands tijdschrift voor geneeskunde 1993;137(13):642-5.
1993: Carin M A Rademaker; A C Fluit; M Jausze; M Rozenberg-Arska; J H Glerum; Jan Verhoef
Enterovirulent Escherichia coli can cause bacteraemia in immunocompromised patients.
The Journal of infection 1993;26(2):226-8.
1993: S Senel; A J Hoogstraate; F Spies; Jan Verhoef; Hans E Junginger; Harry E Boddé
Visualization of enhancing effects of bile salts on buccal penetration.
European journal of morphology 1993;31(1-2):35-41.
1993: Carin M A Rademaker; Ad C Fluit; M Jansze; W H Jansen; J H Glerum; Jan Verhoef
Frequency of enterovirulent Escherichia coli in diarrhoeal disease in The Netherlands.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(2):93-7.
1993: C W H De Fijter; Henri A Verbrugh; E D Peters; PL Oe; Jan van der Meulen; Jan Verhoef; A J M Donker
In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
Clinical nephrology 1993;39(2):75-80.
1993: Carin M A Rademaker; L Martinez-Martinez; E J Perea; M Jansze; Ad C Fluit; J H Glerum; Jan Verhoef
Detection of enterovirulent Escherichia coli associated with diarrhoea in Seville, southern Spain, with non-radioactive DNA probes.
Journal of medical microbiology 1993;38(2):87-9.
1993: P Joling; L J Bakker; Jos van Strijp; T Meerloo; Loek de Graaf; M E Dekker; J Goudsmit; Jan Verhoef; Henk-Jan Schuurman
Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):1065-73.
1993: Ad C Fluit; M J Wolfhagen; M Jansze; Ruurd Torensma; Jan Verhoef
Comment to Knoop et al. (1990) FEBS Letters 267, 9-12, toxin B of Clostridium difficile does not have enolase activity.
FEBS letters 1993;316(1):103-5.
1993: K E Van Vliet; L A De Graaf-Miltenburg; Jan Verhoef; Jos van Strijp
A flow cytometric rosetting assay for the analysis of Fc receptors and C3 receptors on HSV-infected cells.
Journal of immunological methods 1993;157(1-2):57-64.
1993: C M Verduin; C Hol; H J Bootsma; Jan Verhoef; H van Dijk
Observations on constitutional resistance to infection.
Immunology today 1993;14(1):44-5.
1993: AF Verheul; J A Van Gaans; E J Wiertz; Harm Snippe; Jan Verhoef; Jan Poolman
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
Infection and immunity 1993;61(1):187-96.
1993: P Joling; L J Bakker; Dick F van Wichen; Loek de Graaf; T Meerloo; Maarten R Visser; Jos van Strijp; J Goudsmit; Jan Verhoef; Henk-Jan Schuurman
Binding of HIV-1 to human follicular dendritic cells.
Advances in experimental medicine and biology 1993;329():455-60.
1993: Lindsay E Nicolle; A I Hoepelman; M Floor; Jan Verhoef; K Norgard
Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection.
Scandinavian journal of infectious diseases 1993;25(5):631-7.
1993: Annemarie J L Weersink; Kok P M van Kessel; M E van den Tol; Jos van Strijp; Ruurd Torensma; Jan Verhoef; P Elsbach; J Weiss
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):253-63.
1992: Carin M A Rademaker; Maja Rozenberg-Arska; Ad C Fluit; M J Wolfhagen; J H Glerum; Jan Verhoef
[Detection of diarrhea-causing Escherichia coli using DNA-probes].
Nederlands tijdschrift voor geneeskunde 1992;136(52):2581-4.
1992: J F van Iwaarden; Jos van Strijp; H Visser; Henk P Haagsman; Jan Verhoef; Lambert M G van Golde
Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.
The Journal of biological chemistry 1992;267(35):25039-43.
1992: Ruurd Torensma; M J Visser; C J Aarsman; M J Poppelier; R van Beurden; Ad C Fluit; Jan Verhoef
Monoclonal antibodies that detect live salmonellae.
Applied and environmental microbiology 1992;58(12):3868-72.
1992: M N Widjojoatmodjo; Ad C Fluit; Ruurd Torensma; G P Verdonk; Jan Verhoef
The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples.
Journal of clinical microbiology 1992;30(12):3195-9.
1992: H M Frénay; Christina M.J.E, Vandenbroucke-Grauls; M J Molkenboer; Jan Verhoef
Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital.
The Journal of hospital infection 1992;22(3):207-15.
1992: J M Kovarik; Andy I M Hoepelman; J M Smit; P A Sips; Maja Rozenberg-Arska; J H Glerum; Jan Verhoef
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
Antimicrobial agents and chemotherapy 1992;36(11):2458-61.
1992: Maarten R Visser; L Bogaards; Maja Rozenberg-Arska; Jan Verhoef
Comparison of the autoSCAN-W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(11):979-84.
1992: Hans S L M Nottet; I Janse; NM de Vos; L J Bakker; Maarten R Visser; Jan Verhoef
Antibody mediated enhancement of HIV-1 infection of an EBV transformed B cell line is CD4 dependent.
European journal of clinical investigation 1992;22(10):670-5.
1992: C W H De Fijter; Henri A Verbrugh; L P Oe; E D Peters; Jan van der Meulen; A J M Donker; Jan Verhoef
Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.
Kidney international 1992;42(4):947-50.
1992: I M Hoepelman; Jan Verhoef
[New macrolides, azalides and streptogramins; current role and their future perspective].
Nederlands tijdschrift voor geneeskunde 1992;136(38):1847-51.
1992: K E Van Vliet; L A De Graaf-Miltenburg; Jan Verhoef; Jos van Strijp
Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.
Immunology 1992;77(1):109-15.
1992: Jan Verhoef; G Gekker; A Erice; P K Peterson; H H Balfour
Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(8):715-21.
1992: Claus-Michael Lehr; Joke A Bouwstra; W Kok; Albertus G de Boer; J J Tukker; Jan Verhoef; Douwe D Breimer; Hans E Junginger
Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat.
The Journal of pharmacy and pharmacology 1992;44(5):402-7.
1992: J J Cornelissen; A de Graeff; L F Verdonck; T Branger; Maja Rozenberg-Arska; Jan Verhoef; A W Dekker
Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.
Antimicrobial agents and chemotherapy 1992;36(4):801-7.
1992: H E Hofland; Joke A Bouwstra; Jan Verhoef; G Buckton; B Z Chowdry; M Ponec; Hans E Junginger
Safety aspects of non-ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non-ionic surfactants.
The Journal of pharmacy and pharmacology 1992;44(4):287-94.
1992: Donald A Ferguson; E M Veringa; W R Mayberry; B P Overbeek; D W Lambe; Jan Verhoef
Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes.
Microbios 1992;69(278):53-65.
1992: C Timmerman; I Hoepelman; J de Hond; T Boon; L Schreinemachers; H Mensink; Jan Verhoef
Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections.
Infection 1992;20(1):34-7.
1992: L J Bakker; Hans S L M Nottet; NM de Vos; Loek de Graaf; Jos van Strijp; Maarten R Visser; Jan Verhoef
Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes.
AIDS (London, England) 1992;6(1):35-41.
1992: C W H De Fijter; A Biemond; L P Oe; H L Moesker; Jan Verhoef; A J M Donker; Henri A Verbrugh
Pharmacokinetics of ciprofloxacin after intraperitoneal administration in uninfected patients undergoing CCPD.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1992;8():18-21.
1992: R S Oosting; J F Van Iwaarden; Leendert van Bree; Jan Verhoef; Lambert M G van Golde; Henk P Haagsman
Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells.
The American journal of physiology 1992;262(1 Pt 1):L63-8.
1991: Kok P M van Kessel; Jos van Strijp; Jan Verhoef
Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(11):3862-8.
1991: M N Widjojoatmodjo; Ad C Fluit; Ruurd Torensma; B H Keller; Jan Verhoef
Evaluation of the magnetic immuno PCR assay for rapid detection of Salmonella.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(11):935-8.
1991: Ad C Fluit; M J Wolfhagen; G P Verdonk; M Jansze; Ruurd Torensma; Jan Verhoef
Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B.
Journal of clinical microbiology 1991;29(11):2666-7.
1991: AF Verheul; Jan Poolman; Harm Snippe; Jan Verhoef
The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies.
Molecular immunology 1991;28(11):1193-200.
1991: C P Timmerman; André Fleer; J M Besnier; Loek de Graaf; F Cremers; Jan Verhoef
Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene.
Infection and immunity 1991;59(11):4187-92.
1991: AF Verheul; Gerardus Josephus Boons; G A Van der Marel; J H Van Boom; H J Jennings; Harm Snippe; Jan Verhoef; Peter Hoogerhout; Jan Poolman
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.
Infection and immunity 1991;59(10):3566-73.
1991: Frans W H M Merkus; Jan Verhoef; Stefan G Romeijn; N G Schipper
Interspecies differences in the nasal absorption of insulin.
Pharmaceutical research 1991;8(10):1343.
1991: J J Cornelissen; J F Schellekens; CA Kraaijeveld; Jan Verhoef
Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
The Netherlands journal of medicine 1991;39(3-4):170-6.
1991: F R Vogelpoel; R J van Kooij; Egbert R te Velde; Jan Verhoef
Influence of polymorphonuclear granulocytes on the zona-free hamster oocyte assay.
Human reproduction (Oxford, England) 1991;6(8):1104-7.
1991: C P Timmerman; J M Besnier; Loek de Graaf; Ruurd Torensma; A J Verkley; André Fleer; Jan Verhoef
Characterisation and functional aspects of monoclonal antibodies specific for surface proteins of coagulase-negative staphylococci.
Journal of medical microbiology 1991;35(2):65-71.
1991: R S Oosting; Marleen M J van Greevenbroek; Jan Verhoef; Lambert M G van Golde; Henk P Haagsman
Structural and functional changes of surfactant protein A induced by ozone.
The American journal of physiology 1991;261(2 Pt 1):L77-83.
1991: Carin M A Rademaker; M R Krul; W H Jansen; N M Vos; Ilja M Hoepelman; Maja Rozenberg-Arska; Jan Verhoef
Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(8):625-9.
1991: J F van Iwaarden; Jos van Strijp; M J Ebskamp; A C Welmers; Jan Verhoef; Lambert M G van Golde
Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages.
The American journal of physiology 1991;261(2 Pt 1):L204-9.
1991: R S Oosting; Lambert M G van Golde; Jan Verhoef; Leendert van Bree
Species differences in impairment and recovery of alveolar macrophage functions following single and repeated ozone exposures.
Toxicology and applied pharmacology 1991;110(1):170-8.
1991: N G Schipper; Jan Verhoef; Frans W H M Merkus
The nasal mucociliary clearance: relevance to nasal drug delivery.
Pharmaceutical research 1991;8(7):807-14.
1991: Ruurd Torensma; A van Wijk; M J Visser; A Bouter; Maja Rozenberg-Arska; Jan Verhoef
Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli.
Journal of clinical microbiology 1991;29(7):1356-8.
1991: M A Muijsken; H J Heezius; Jan Verhoef; Henri A Verbrugh
Role of mesothelial cells in peritoneal antibacterial defence.
Journal of clinical pathology 1991;44(7):600-4.
1991: Jan Verhoef
Selective decontamination of the intestines: an important clinical treatment modality?
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(6):477-8.
1991: Frans W H M Merkus; Jan Verhoef; Stefan G Romeijn; N G Schipper
Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.
Pharmaceutical research 1991;8(5):588-92.
1991: Maarten R Visser; Maja Rozenberg-Arska; H Beumer; Ilja M Hoepelman; Jan Verhoef
Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.
Antimicrobial agents and chemotherapy 1991;35(5):858-68.
1991: Jos van Strijp; M E van der Tol; L A Miltenburg; Kok P M van Kessel; Jan Verhoef
Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.
Immunology 1991;73(1):77-82.
1991: J J Cornelissen; C P Van Kessel; E Brouwer; CA Kraaijeveld; Jan Verhoef
Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin.
Journal of medical microbiology 1991;34(4):233-8.
1991: A Weersink; M Visser; A Vos; PF Hulstaert; I ten Berge; M Muijsken; Th J M V van Vroonhoven; Jan Verhoef
Amoxicillin-clavulanate prophylaxis against wound infections after clean-contaminated surgery. A controlled, randomized, prospective study.
The European journal of surgery = Acta chirurgica 1991;157(4):271-5.
1991: Maja Rozenberg-Arska; A W Dekker; J Branger; Jan Verhoef
A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.
The Journal of antimicrobial chemotherapy 1991;27(3):369-76.
1991: AF Verheul; AK Braat; J M Leenhouts; Peter Hoogerhout; Jan Poolman; Harm Snippe; Jan Verhoef
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.
Infection and immunity 1991;59(3):843-51.
1991: Jan Verhoef
The phagocytic process and the role of complement in host defense.
Journal of chemotherapy (Florence, Italy) 1991;3 Suppl 1():93-7.
1991: Jan Verhoef
Host-pathogen relationships in respiratory tract infections.
Clinical therapeutics 1991;13(1):172-80.
1991: J B van Bree; J W van Nispen; Jan Verhoef; Douwe D Breimer
Development of specific antisera against 9-desglycinamide-8-arginine vasopressin by site-specific immunization.
Journal of pharmaceutical sciences 1991;80(1):46-9.
1991: Christina M.J.E, Vandenbroucke-Grauls; H M Frénay; B van Klingeren; T F Savelkoul; Jan Verhoef
Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(1):6-11.
1991: PC Ligtenberg; Ilja M Hoepelman; G A Oude Sogtoen; Adriaan W Dekker; I van der Tweel; Maja Rozenberg-Arska; Jan Verhoef
C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(1):25-31.
1991: M E de Vries; Harry E Boddé; Jan Verhoef; Hans E Junginger
Developments in buccal drug delivery.
Critical reviews in therapeutic drug carrier systems 1991;8(3):271-303.
1991: N Keller; GM Raponi; Ilja M Hoepelman; B P Overbeek; Maja Rozenberg-Arska; Jan Verhoef
Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1991;274(4):519-26.
1991: Maja Rozenberg-Arska; A W Dekker; Jan Verhoef
Prevention of infections in granulocytopenic patients by fluorinated quinolones.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1991;121():337-46.
1991: GM Raponi; N Keller; B P Overbeek; Maja Rozenberg-Arska; Ruurd Torensma; Jan Verhoef
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
The Journal of infectious diseases 1991;163(1):122-7.
1991: C W H De Fijter; Henri A Verbrugh; PL Oe; E D Peters; Jan van der Meulen; A J M Donker; Jan Verhoef; N Lameire
The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1991;7():154-7.
1991: C W H De Fijter; Henri A Verbrugh; E D Peters; PL Oe; Jan van der Meulen; A J M Donker; Jan Verhoef
Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1991;7():150-3.
1990: J M Kovarik; J A de Hond; Ilja M Hoepelman; T Boon; Jan Verhoef
Intraprostatic distribution of lomefloxacin following multiple-dose administration.
Antimicrobial agents and chemotherapy 1990;34(12):2398-401.
1990: Carin M A Rademaker; A P Sips; H M Beumer; Ilja M Hoepelman; B P Overbeek; M J Möllers; Maja Rozenberg-Arska; Jan Verhoef
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
The Journal of antimicrobial chemotherapy 1990;26 Suppl D():75-81.
1990: Jan Verhoef
Transient immunodepression.
The Journal of antimicrobial chemotherapy 1990;26 Suppl C():23-9.
1990: J M Kovarik; J C ter Maaten; Carin M A Rademaker; M Deenstra; Ilja M Hoepelman; H C Hart; G R Matzke; Jan Verhoef
Pharmacokinetics of cefepime in patients with respiratory tract infections.
Antimicrobial agents and chemotherapy 1990;34(10):1885-8.
1990: André Fleer; C P Timmerman; J M Besnier; A Pascual; Jan Verhoef
Surface proteins of coagulase-negative staphylococci: their role in adherence to biomaterials and in opsonization.
Journal of biomaterials applications 1990;5(2):154-65.
1990: C W H De Fijter; Henri A Verbrugh; H C Heezius; Jan van der Meulen; PL Oe; A J M Donker; Jan Verhoef
Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages.
The Journal of antimicrobial chemotherapy 1990;26(4):525-32.
1990: Kok P M van Kessel; Jos van Strijp; H J van Kats-Renaud; L A Miltenburg; Ad C Fluit; Jan Verhoef
Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient.
Journal of leukocyte biology 1990;48(4):359-66.
1990: Ad C Fluit; A T Box; Jan Verhoef
A probe for the detection of methicillin-resistant Staphylococcus aureus.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(8):605-8.
1990: R S Oosting; Leendert van Bree; J F van Iwaarden; Lambert M G van Golde; Jan Verhoef
Impairment of phagocytic functions of alveolar macrophages by hydrogen peroxide.
The American journal of physiology 1990;259(2 Pt 1):L87-94.
1990: Annemarie J L Weersink; Kok P M van Kessel; Ruurd Torensma; Jos van Strijp; Jan Verhoef
Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(1):318-24.
1990: H M Frénay; Christina M.J.E, Vandenbroucke-Grauls; T J Savelkoul; J H Rommes; B van Klingeren; Jan Verhoef
[Spread and control of a methicillin-resistant Staphylococcus aureus in an academic hospital].
Nederlands tijdschrift voor geneeskunde 1990;134(24):1169-73.
1990: Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
[The control of methicillin-resistant Staphylococcus aureus; worthwhile?].
Nederlands tijdschrift voor geneeskunde 1990;134(24):1163-5.
1990: J J Cornelissen; T A Oosterlaken; J Schellekens; Ruurd Torensma; M Rozenberg-Arska; CA Kraaijeveld; Jan Verhoef
Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A.
Journal of immunological methods 1990;130(1):141-7.
1990: N A van der Wal; J F van Oirschot; A van Dijk; Jan Verhoef; B Sweder van Asbeck
Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine.
Biochemical pharmacology 1990;39(11):1665-71.
1990: W A Hermens; M J Deurloo; S G Romeyn; Jan Verhoef; Frans W H M Merkus
Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
Pharmaceutical research 1990;7(5):500-3.
1990: Herman Goossens; Bruno Pot; L Vlaes; C Van den Borre; R Van den Abbeele; C Van Naelten; J Levy; H Cogniau; P Marbehant; Jan Verhoef
Characterization and description of "Campylobacter upsaliensis" isolated from human feces.
Journal of clinical microbiology 1990;28(5):1039-46.
1990: S P M Geelen; André Fleer; A C Bezemer; Leo J Gerards; Ger T Rijkers; Jan Verhoef
Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
Pediatric research 1990;27(5):514-8.
1990: Jos van Strijp; L A Miltenburg; M E van der Tol; Kok P M van Kessel; Ad C Fluit; Jan Verhoef
Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes.
The Journal of general virology 1990;71 ( Pt 5)():1205-9.
1990: F R Vogelpoel; R J Van Kooij; Egbert R te Velde; Jan Verhoef
Influence of complement on sperm motility.
International journal of andrology 1990;13(2):81-6.
1990: Jan Verhoef; Ruurd Torensma
Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(4):247-50.
1990: M J Wolfhagen; Ilja M Hoepelman; Jan Verhoef
[Urinary tract infection in the elderly; what does it mean?].
Nederlands tijdschrift voor geneeskunde 1990;134(10):470-3.
1990: J B van Bree; S Tio; Albertus G de Boer; Meindert Danhof; Jan Verhoef; Douwe D Breimer
Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology.
Pharmaceutical research 1990;7(3):293-8.
1990: M J Wolfhagen; Andy I M Hoepelman; Jan Verhoef
Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections.
Antimicrobial agents and chemotherapy 1990;34(3):409-12.
1990: J de Jongh-Leuvenink; J Schellekens; Jan Verhoef
Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.
Infection and immunity 1990;58(2):421-6.
1990: I A Haagen; H C Heezius; R P Verkooyen; Jan Verhoef; Henri A Verbrugh
Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers.
The Journal of infectious diseases 1990;161(2):266-73.
1990: GM Raponi; N Keller; B P Overbeek; Maja Rozenberg-Arska; K P van Kessel; Jan Verhoef
Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.
Antimicrobial agents and chemotherapy 1990;34(2):332-6.
1990: E J van Hoogdalem; C D Heijligers-Feijen; Jan Verhoef; Albertus G de Boer; Douwe D Breimer
Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
Pharmaceutical research 1990;7(2):180-3.
1990: F van Iwaarden; B Welmers; Jan Verhoef; Henk P Haagsman; Lambert M G van Golde
Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.
American journal of respiratory cell and molecular biology 1990;2(1):91-8.
1990: Ilja M Hoepelman; W A Bezemer; Christina M.J.E, Vandenbroucke-Grauls; Joannes Marx; Jan Verhoef
Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes.
Infection and immunity 1990;58(1):26-31.
1990: J Kovarik; M Rozenberg-Arska; M Visser; Jan Verhoef
Pharmacodynamics of cefepime.
Scandinavian journal of infectious diseases. Supplementum 1990;74():270-3.
1990: H van Bronswijk; Henri A Verbrugh; E C Heezius; R P Verkooyen; Jan van der Meulen; Jan Verhoef
Host defence in CAPD treatment: the effect of the dialysate on cell function.
Contributions to nephrology 1990;85():67-72.
1989: T Erich; J Schellekens; A Bouter; J Van Kranen; E Brouwer; Jan Verhoef
Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(12):4053-60.
1989: Carin M A Rademaker; R W Jones; L J Notarianni; Aalt van Dijk; J H Glerum; Jan Verhoef
Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models.
Pharmaceutisch weekblad. Scientific edition 1989;11(6):224-8.
1989: Maarten R Visser; Ilja M Hoepelman; H Beumer; Maja Rozenberg-Arska; Jan Verhoef
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(12):1061-4.
1989: Ad C Fluit; Jos van Strijp; L A Miltenburg; C P van Kessel; H Snippe; Jan Verhoef
The use of a hybridization assay for the study of host defences against herpes simplex virus.
Journal of virological methods 1989;26(3):269-78.
1989: E J van Hoogdalem; C D Heijligers-Feijen; R A Mathôt; A T Wackwitz; J B van Bree; Jan Verhoef; Albertus G de Boer; Douwe D Breimer
Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
The Journal of pharmacology and experimental therapeutics 1989;251(2):741-4.
1989: Kok P M van Kessel; Jos van Strijp; M E van der Tol; H J van Kats-Renaud; R M Thijssen; Ad C Fluit; Jan Verhoef
Quantitation of conjugate formation between human polymorphonuclear leukocytes and antibody-coated target cells by flow cytometry: the role of Fc receptor and LFA-1 antigen.
Journal of leukocyte biology 1989;46(5):467-75.
1989: Jan Verhoef; M Rozenberg-Arska; A Dekker
Prevention of infection in the neutropenic patient.
Reviews of infectious diseases 1989;11 Suppl 7():S1545-50.
1989: M J Deurloo; W A Hermens; S G Romeyn; Jan Verhoef; Frans W H M Merkus
Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Pharmaceutical research 1989;6(10):853-6.
1989: H E Bodde; Jan Verhoef; M Ponec
Transdermal peptide delivery.
Biochemical Society transactions 1989;17(5):943-5.
1989: Jan Verhoef; Maja Rozenberg-Arska; A W Dekker
Prevention of bacterial and fungal infections in granulocytopenic patients.
European journal of cancer & clinical oncology 1989;25(9):1345-50.
1989: E M Veringa; Donald A Ferguson; D W Lambe; Jan Verhoef
Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1989;271(3):311-20.
1989: J M Kovarik; Ilja M Hoepelman; Jan Verhoef
Once-daily aminoglycoside administration: new strategies for an old drug.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(9):761-9.
1989: Ilja M Hoepelman; W A Bezemer; E van Doornmalen; Jan Verhoef; Joannes Marx
Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes.
British journal of haematology 1989;72(4):584-8.
1989: Carin M A Rademaker; Ilja M Hoepelman; M J Wolfhagen; H Beumer; Maja Rozenberg-Arska; Jan Verhoef
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(8):690-4.
1989: Maja Rozenberg-Arska; A Dekker; L Verdonck; Jan Verhoef
Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.
Infection 1989;17(4):240-4.
1989: M Rozenberg-Arska; A W Dekker; Jan Verhoef
Prevention of infections in granulocytopenic patients by fluorinated quinolones.
Reviews of infectious diseases 1989;11 Suppl 5():S1231-6.
1989: Christina M.J.E, Vandenbroucke-Grauls; H M Thijssen; P A Tetteroo; E Rozemuller; Jan Verhoef
Increased expression of leucocyte adherence-related glycoproteins by polymorphonuclear leucocytes during phagocytosis of staphylococci on an endothelial surface.
Scandinavian journal of immunology 1989;30(1):91-8.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Jan Verhoef
Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.
The Journal of clinical investigation 1989;84(1):107-12.
1989: J B van Bree; Albertus G de Boer; Jan Verhoef; Meindert Danhof; Douwe D Breimer
Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
The Journal of pharmacology and experimental therapeutics 1989;249(3):901-5.
1989: H van Bronswijk; Henri A Verbrugh; H C Heezius; N H Renders; A Fleer; Jan van der Meulen; PL Oe; Jan Verhoef
Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
Immunology 1989;67(1):81-6.
1989: J M Kovarik; Ilja M Hoepelman; Jan Verhoef
Influence of fluoroquinolones on expression and function of P fimbriae in uropathogenic Escherichia coli.
Antimicrobial agents and chemotherapy 1989;33(5):684-8.
1989: E M Veringa; Donald A Ferguson; D W Lambe; Jan Verhoef
The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin.
The Journal of antimicrobial chemotherapy 1989;23(5):711-20.
1989: E M Veringa; D W Lambe; Donald A Ferguson; Jan Verhoef
Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations.
The Journal of antimicrobial chemotherapy 1989;23(4):577-87.
1989: GM Raponi; R W Vreede; Maja Rozenberg-Arska; Ilja M Hoepelman; N Keller; Jan Verhoef
The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences.
The Journal of antimicrobial chemotherapy 1989;23(4):565-76.
1989: Kok P M van Kessel; Jos van Strijp; L M Miltenburg; H J Van Kats-Renaud; Ad C Fluit; Jan Verhoef
Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes.
Journal of immunological methods 1989;118(2):279-85.
1989: T Erich; B Dekker; M De Beer; Ruurd Torensma; Jan Verhoef
In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas.
Journal of immunological methods 1989;118(1):17-24.
1989: I M Hoepelman; M Rozenberg-Arska; Jan Verhoef
[Monotherapy or combination therapy in severe bacterial infections?].
Nederlands tijdschrift voor geneeskunde 1989;133(6):284-6.
1989: GM Raponi; N Keller; Maja Rozenberg-Arska; Ilja M Hoepelman; Jan Verhoef
The influence of cefepime on opsonophagocytosis of bacteria.
Drugs under experimental and clinical research 1989;15(4):141-4.
1989: C W H De Fijter; Henri A Verbrugh; H C Heezius; H van Bronswijk; Jan van der Meulen; PL Oe; A J M Donker; Jan Verhoef
Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1989;5():124-7.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Ad C Fluit; Harm Snippe; Jan Verhoef
Phagocytosis of herpes simplex virus by human granulocytes and monocytes.
Archives of virology 1989;104(3-4):287-98.
1989: E J van Hoogdalem; C D Heijligers-Feijen; Albertus G de Boer; Jan Verhoef; Douwe D Breimer
Rectal absorption enhancement of des-enkephalin-gamma-endorphin (DE gamma E) by medium-chain glycerides and EDTA in conscious rats.
Pharmaceutical research 1989;6(1):91-5.
1989: H van Bronswijk; Henri A Verbrugh; H J Bos; E C Heezius; PL Oe; Jan van der Meulen; Jan Verhoef
Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1989;9(3):197-202.
1989: A Fleer; Jan Verhoef
An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 1989;2(4):391-6.
1988: Ilja M Hoepelman; E Y Jaarsma; Jan Verhoef; Joannes Marx
Effect of iron on polymorphonuclear granulocyte phagocytic capacity: role of oxidation state and effect of ascorbic acid.
British journal of haematology 1988;70(4):495-500.
1988: A J Kerver; J H Rommes; E A Mevissen-Verhage; PF Hulstaert; A Vos; Jan Verhoef; P Wittebol
Prevention of colonization and infection in critically ill patients: a prospective randomized study.
Critical care medicine 1988;16(11):1087-93.
1988: Christina M.J.E, Vandenbroucke-Grauls; A J Kerver; J H Rommes; R Jansen; C den Dekker; Jan Verhoef
Endemic Acinetobacter anitratus in a surgical intensive care unit: mechanical ventilators as reservoir.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(4):485-9.
1988: T Calandra; Michel-Pierre Glauser; J Schellekens; Jan Verhoef
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
The Journal of infectious diseases 1988;158(2):312-9.
1988: Ilja M Hoepelman; Maja Rozenberg-Arska; Jan Verhoef
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections.
Lancet 1988;1(8598):1305-9.
1988: H van Bronswijk; Henri A Verbrugh; H C Heezius; Jan van der Meulen; PL Oe; Jan Verhoef
Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(3):368-73.
1988: J B van Bree; Albertus G de Boer; Meindert Danhof; Jan Verhoef; T B van Wimersma Greidanus; Douwe D Breimer
Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the rat.
Peptides 1988;9(3):555-9.
1988: Andy I M Hoepelman; L J Bakker; Jan Verhoef
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Antimicrobial agents and chemotherapy 1988;32(4):473-6.
1988: A Pascual; André Fleer; N A Westerdaal; M Berghuis; Jan Verhoef
Surface hydrophobicity and opsonic requirements of coagulase-negative staphylococci in suspension and adhering to a polymer substratum.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(2):161-6.
1988: Ilja M Hoepelman; E Y Jaarsma; Jan Verhoef; Joannes Marx
Polynuclear iron complexes impair the function of polymorphonuclear granulocytes.
British journal of haematology 1988;68(3):385-9.
1988: Jos van Strijp; Kok P M van Kessel; L A Miltenburg; Ad C Fluit; Jan Verhoef
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.
Journal of virology 1988;62(3):847-50.
1988: M J Wolfhagen; Ilja M Hoepelman; R A de Melker; Jan Verhoef
[Diagnosis of uncomplicated urinary tract infections: complicated?].
Nederlands tijdschrift voor geneeskunde 1988;132(9):390-4.
1988: André Fleer; Leo J Gerards; Jan Verhoef
Host defence to bacterial infection in the neonate.
The Journal of hospital infection 1988;11 Suppl A():320-7.
1988: E Veringa; A Box; Maja Rozenberg-Arska; Jan Verhoef
Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
Drugs under experimental and clinical research 1988;14(1):1-8.
1988: André Fleer; J J Roord; C Neeleman; H Timmerman; Jan Verhoef; J W Stoop
Metabolic activation of human polymorphonuclear leukocytes by opsonized Haemophilus influenzae type b.
Acta paediatrica Hungarica 1988;29(1-2):131-5.
1988: Ilja M Hoepelman; Maja Rozenberg-Arska; Jan Verhoef
Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora.
Chemotherapy 1988;34 Suppl 1():21-9.
1988: Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
Bacteria, phagocytes, and bystander cells. Interaction between Staphylococcus aureus, polymorphonuclear leukocytes, and endothelial cells.
Pathology and immunopathology research 1988;7(3):149-61.
1987: Kok P M van Kessel; Jos van Strijp; H J Van Kats-Renaud; L A Miltenburg; M E Van Der Tol; Ad C Fluit; Jan Verhoef
Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.
Immunology 1987;62(4):675-8.
1987: F Vlaspolder; G de Zeeuw; Maja Rozenberg-Arska; P Egyedi; Jan Verhoef
The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract.
Infection 1987;15(4):241-4.
1987: Christina M.J.E, Vandenbroucke-Grauls; H M Thijssen; K P van Kessel; B S van Asbeck; Jan Verhoef
Injury to endothelial cells by phagocytosing polymorphonuclear leukocytes and modulatory role of lipoxygenase products.
Infection and immunity 1987;55(6):1447-54.
1987: Christina M.J.E, Vandenbroucke-Grauls; H M Thijssen; Jan Verhoef
Opsonization of Staphylococcus aureus protects endothelial cells from damage by phagocytosing polymorphonuclear leukocytes.
Infection and immunity 1987;55(6):1455-60.
1987: B P Overbeek; J F Schellekens; W Lippe; B A Dekker; Jan Verhoef
Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5.
Journal of clinical microbiology 1987;25(6):1009-13.
1987: K N Ward; A Fleer; Jan Verhoef; D M Jones
Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains.
Journal of clinical pathology 1987;40(4):361-7.
1987: Henri A Verbrugh; H van Bronswijk; Jan van der Meulen; PL Oe; Jan Verhoef
Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor.
Contributions to nephrology 1987;57():85-91.
1987: A J Kerver; J H Rommes; E A Mevissen-Verhage; PF Hulstaert; A Vos; Jan Verhoef; P Wittebol
Colonization and infection in surgical intensive care patients--a prospective study.
Intensive care medicine 1987;13(5):347-51.
1987: E M Veringa; Jan Verhoef
Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
Chemotherapy 1987;33(4):243-9.
1987: I M Hoepelman; G Steyger; M Rozenberg-Arska; Jan Verhoef
Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics.
Chemotherapy 1987;33(2):103-9.
1987: I M Hoepelman; Jan Verhoef
Antimicrobial agents and opsonic defence.
Annali dell'Istituto superiore di sanità 1987;23(4):921-3.
1987: F R Vogelpoel; Egbert R te Velde; E Scheenjes; R Van Kooy; J Kremer; Jan Verhoef
Antibody and complement-binding activity of viable and nonviable human spermatozoa.
Archives of andrology 1987;18(3):189-97.
1986: E M Veringa; Jan Verhoef
Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process.
Antimicrobial agents and chemotherapy 1986;30(5):796-7.
1986: I M Hoepelman; Jan Verhoef
[Chemotherapeutic agents and antibiotics in urinary tract infections].
Nederlands tijdschrift voor geneeskunde 1986;130(40):1788-90.
1986: A Pascual; André Fleer; N A Westerdaal; Jan Verhoef
Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro.
European journal of clinical microbiology 1986;5(5):518-22.
1986: M Rozenberg-Arska; J C Porsius; E Y Jaarsma; Jan Verhoef
Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
Journal of medical microbiology 1986;22(2):143-9.
1986: A Fleer; Jan Verhoef; A Pascual Hernandez
Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity.
The American journal of medicine 1986;80(6B):161-5.
1986: R W Vreede; J H Marcelis; Jan Verhoef
Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
Infection and immunity 1986;52(3):892-6.
1986: P A Henricks; Jan Verhoef; F P Nijkamp
Modulation of phagocytic cell function.
Veterinary research communications 1986;10(3):165-88.
1986: Kok P M van Kessel; H J Van Kats-Renaud; Jos van Strijp; Maarten R Visser; Jan Verhoef
Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
Journal of immunological methods 1986;88(1):101-7.
1986: R W Vreede; J Leuvenink; A S Bouter; E C Brouwer; J H Marcelis; Jan Verhoef
Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
European journal of clinical microbiology 1986;5(2):141-7.
1986: J de Jongh-Leuvenink; A S Bouter; J H Marcelis; J Schellekens; Jan Verhoef
Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
European journal of clinical microbiology 1986;5(2):148-51.
1986: P A J Henricks; M E van der Tol; Ferdi Engels; F P Nijkamp; Jan Verhoef
Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis of Staphylococcus aureus.
Inflammation 1986;10(1):37-47.
1986: P A Henricks; M van der Tol; Jan Verhoef
Production of leukotriene B4 by polymorphonuclear leukocytes during phagocytosis of Staphylococcus aureus.
Agents and actions 1986;17(3-4):388-9.
1985: P A J Henricks; M E van der Tol; Jan Verhoef
Interactions between human polymorphonuclear leukocytes and influenza virus.
Scandinavian journal of immunology 1985;22(6):721-5.
1985: M Rozenberg-Arska; B S Van Asbeck; T F Martens; Jan Verhoef
Damage to chromosomal and plasmid DNA by toxic oxygen species.
Journal of general microbiology 1985;131(12):3325-30.
1985: E A Mevissen-Verhage; J H Marcelis; P A Guinée; Jan Verhoef
Effect of iron on serotypes and haemagglutination patterns of Escherichia coli in bottle-fed infants.
European journal of clinical microbiology 1985;4(6):570-4.
1985: M Rozenberg-Arska; M E Salters; Jos van Strijp; J J Geuze; Jan Verhoef
Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes.
Infection and immunity 1985;50(3):852-9.
1985: J de Jongh-Leuvenink; R W Vreede; J H Marcelis; M de Vos; Jan Verhoef
Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
Infection and immunity 1985;50(3):716-20.
1985: André Fleer; Leo J Gerards; P Aerts; N A Westerdaal; R C Senders; H van Dijk; Jan Verhoef
Opsonic defense to Staphylococcus epidermidis in the premature neonate.
The Journal of infectious diseases 1985;152(5):930-7.
1985: Christina M.J.E, Vandenbroucke-Grauls; H M Thijssen; Jan Verhoef
Phagocytosis of staphylococci by human polymorphonuclear leukocytes is enhanced in the presence of endothelial cells.
Infection and immunity 1985;50(1):250-4.
1985: E S Kalter; F C Jaspers; W C van Dijk; F P Nijkamp; W de Jong; Jan Verhoef
Induction of the early hypotensive phase by Escherichia coli: role of bacterial surface structures and inflammatory mediators.
The Journal of infectious diseases 1985;152(3):493-9.
1985: M Rozenberg-Arska; A W Dekker; Jan Verhoef
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
The Journal of infectious diseases 1985;152(1):104-7.
1985: E A Mevissen-Verhage; J H Marcelis; W C Harmsen-Van Amerongen; N M de Vos; Jan Verhoef
Effect of iron on neonatal gut flora during the first three months of life.
European journal of clinical microbiology 1985;4(3):273-8.
1985: E S Kalter; M R Daha; J W ten Cate; Jan Verhoef; B N Bouma
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.
The Journal of infectious diseases 1985;151(6):1019-27.
1985: B P Overbeek; M Rozenberg-Arska; Jan Verhoef
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro.
European journal of clinical microbiology 1985;4(2):140-1.
1985: Jan Verhoef
[The prescribing of antibiotics].
Nederlands tijdschrift voor geneeskunde 1985;129(13):581-3.
1985: H van Velzen-Blad; Y J Dijkstra; G A Schurink; Henri A Verbrugh; Jan Verhoef; B J Zegers; R E Ballieux
Cardiopulmonary bypass and host defense functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis.
The Annals of thoracic surgery 1985;39(3):207-11.
1985: R W Vreede; Jan Verhoef
[The interaction between food, nutritional status, metabolism and orally administered antimicrobial agents].
Nederlands tijdschrift voor geneeskunde 1985;129(2):55-8.
1985: B P Overbeek; Maja Rozenberg-Arska; Jan Verhoef
Do quinolones really augment the antifungal effect of amphotericin B in vitro?
Drugs under experimental and clinical research 1985;11(11):745-6.
1984: P A J Henricks; M E Van der Tol; J H Van Kats-Renaud; F P Nijkamp; Jan Verhoef
Differences in the effect of arachidonic acid on polymorphonuclear and mononuclear leukocyte function.
Biochimica et biophysica acta 1984;801(2):206-14.
1984: P A J Henricks; M E van der Tol; Jan Verhoef
Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria.
Immunology 1984;52(4):671-8.
1984: Christina M.J.E, Vandenbroucke-Grauls; H M Thijssen; Jan Verhoef
Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.
Immunology 1984;52(3):427-35.
1984: B S van Asbeck; Joannes Marx; A Struyvenberg; Jan Verhoef
Functional defects in phagocytic cells from patients with iron overload.
The Journal of infection 1984;8(3):232-40.
1984: M Rozenberg-Arska; Jos van Strijp; W P Hoekstra; Jan Verhoef
Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase.
The Journal of clinical investigation 1984;73(5):1254-62.
1984: B S van Asbeck; Joannes Marx; A Struyvenberg; J H van Kats; Jan Verhoef
Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes.
Blood 1984;63(3):714-20.
1984: Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
Acquired immune deficiency syndrome in the Netherlands.
European journal of clinical microbiology 1984;3(1):62.
1984: B S van Asbeck; Joannes Marx; A Struyvenberg; J H van Kats; Jan Verhoef
Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(2):851-6.
1984: Christina M.J.E, Vandenbroucke-Grauls; R M Thijssen; J H Marcelis; S D Sharma; Jan Verhoef
Effects of lysosomotropic amines on human polymorphonuclear leucocyte function.
Immunology 1984;51(2):319-26.
1984: A Fleer; Jan Verhoef
New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens.
Antonie van Leeuwenhoek 1984;50(5-6):729-44.
1984: J F Schellekens; E S Kalter; R W Vreede; Jan Verhoef
Host-parasite interaction in serious infections due to gram-negative bacteria.
Antonie van Leeuwenhoek 1984;50(5-6):701-10.
1984: M Rozenberg-Arska; E C Salters; Jos van Strijp; W P Hoekstra; Jan Verhoef
Degradation of Escherichia coli chromosomal and plasmid DNA in serum.
Journal of general microbiology 1984;130(1):217-22.
1983: André Fleer; R C Senders; M R Visser; R P Bijlmer; Leo J Gerards; C A Kraaijeveld; Jan Verhoef
Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis.
Pediatric infectious disease 1983;2(6):426-31.
1983: B S van Asbeck; J H Marcelis; Joannes Marx; A Struyvenberg; J H van Kats; Jan Verhoef
Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.
European journal of clinical microbiology 1983;2(5):426-31.
1983: E S Kalter; W C van Dijk; A Timmerman; Jan Verhoef; B N Bouma
Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.
The Journal of infectious diseases 1983;148(4):682-91.
1983: B S van Asbeck; J H Marcelis; J H van Kats; E Y Jaarsma; Jan Verhoef
Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.
European journal of clinical microbiology 1983;2(5):432-8.
1983: D Milatovic; I Braveny; Jan Verhoef
Clindamycin enhances opsonization of Staphylococcus aureus.
Antimicrobial agents and chemotherapy 1983;24(3):413-7.
1983: P A J Henricks; M E van der Tol; R M Thyssen; B S van Asbeck; Jan Verhoef
Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes.
Infection and immunity 1983;41(1):294-301.
1983: M Rozenberg-Arska; A W Dekker; Jan Verhoef
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
Infection 1983;11(3):167-9.
1983: B S van Asbeck; Jan Verhoef
Iron and host defence.
European journal of clinical microbiology 1983;2(1):6-10.
1983: Jan Verhoef; D M Musher; John Spika; Henri A Verbrugh; F C Jaspers
The effect of staphylococcal peptidoglycan on polymorphonuclear leukocytes in vitro and in vivo.
Scandinavian journal of infectious diseases. Supplementum 1983;41():79-86.
1983: P K Peterson; P G Quie; Y Kim; B J Wilkinson; Henri A Verbrugh; Jan Verhoef
Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface.
Scandinavian journal of infectious diseases. Supplementum 1983;41():67-78.
1983: Jan Verhoef; A Fleer
Staphylococcus epidermidis endocarditis and Staphylococcus epidermidis infection in an intensive care unit.
Scandinavian journal of infectious diseases. Supplementum 1983;41():56-64.
1983: Henri A Verbrugh; Jan Verhoef; B J Wilkinson; P K Peterson
Biology and clinical significance of peptidoglycan antibody response in staphylococcal infections.
Scandinavian journal of infectious diseases. Supplementum 1983;41():117-25.
1982: Christina M.J.E, Vandenbroucke-Grauls; M Rozenberg-Arska; C W den Hengst; Jan Verhoef
Prostatitis due to penicillinase-producing Neisseria gonorrhoeae. Case reports.
The British journal of venereal diseases 1982;58(5):311-3.
1982: John Spika; P K Peterson; B J Wilkinson; D E Hammerschmidt; Henri A Verbrugh; Jan Verhoef; P G Quie
Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.
The Journal of infectious diseases 1982;146(2):227-34.
1982: P A Henricks; M E van Erne-van der Tol; Jan Verhoef
Partial removal of sialic acid enhances phagocytosis and the generation of superoxide and chemiluminescence by polymorphonuclear leukocytes.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(2):745-50.
1982: W C van Dijk; Henri A Verbrugh; R E van Rijswijk; A Vos; Jan Verhoef
Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients.
Surgery 1982;92(1):21-9.
1982: Y Debets-Ossenkopp; E L Mills; W C van Dijk; Henri A Verbrugh; Jan Verhoef
Effect of influenza virus on phagocytic cells.
European journal of clinical microbiology 1982;1(3):171-7.
1982: T Meshulam; Henri A Verbrugh; Jan Verhoef
Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
European journal of clinical microbiology 1982;1(2):112-7.
1982: B S van Asbeck; Henri A Verbrugh; B A van Oost; Joannes Marx; H W Imhof; Jan Verhoef
Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.
British medical journal (Clinical research ed.) 1982;284(6315):542-4.
1982: Jan Verhoef; E L Mills; Y Debets-Ossenkopp; Henri A Verbrugh
The effect of influenza virus on oxygen-dependent metabolism of human neutrophils.
Advances in experimental medicine and biology 1982;141():647-54.
1982: Henri A Verbrugh; J R Hoidal; B Y Nguyen; Jan Verhoef; P G Quie; P K Peterson
Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.
The Journal of clinical investigation 1982;69(1):63-74.
1981: John Spika; Henri A Verbrugh; Jan Verhoef
Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.
Infection and immunity 1981;34(2):455-60.
1981: W C van Dijk; Henri A Verbrugh; M E van Erne-van der Tol; R Peters; Jan Verhoef
Escherichia coli antibodies in opsonisation and protection against infection.
Journal of medical microbiology 1981;14(4):381-9.
1981: A W Dekker; M Rozenberg-Arska; J J Sixma; Jan Verhoef
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
Annals of internal medicine 1981;95(5):555-9.
1981: Henri A Verbrugh; P K Peterson; D E Smith; B Y Nguyen; J R Hoidal; B J Wilkinson; Jan Verhoef; L T Furcht
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages.
Infection and immunity 1981;33(3):811-9.
1981: Henri A Verbrugh; R Peters; M Rozenberg-Arska; P K Peterson; Jan Verhoef
Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections.
The Journal of infectious diseases 1981;144(1):1-9.
1981: D M Musher; Henri A Verbrugh; Jan Verhoef
Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(1):84-8.
1981: Jan Verhoef; Henri A Verbrugh
Host determinants in staphylococcal disease.
Annual review of medicine 1981;32():107-22.
1980: W C van Dijk; Henri A Verbrugh; M E van der Tol; R Peters; P K Peterson; P G Quie; Jan Verhoef
Interactions of phagocytic and bacterial cells in patients with bacteremia caused by gram-negative rods.
The Journal of infectious diseases 1980;141(4):441-9.
1980: Henri A Verbrugh; W C van Dijk; R Peters; M E van Erne; M R Daha; P K Peterson; Jan Verhoef
Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(3):1167-73.
1980: Y Debets-Ossenkopp; W C van Dijk; E L Mills; Henri A Verbrugh; Jan Verhoef
The effect of influenza virus on human polymorphonuclear leukocytes.
Antonie van Leeuwenhoek 1980;46(1):103.
1980: Henri A Verbrugh; W C van Dijk; G F Hendrickx; D van der Stadt; J W Stoop; P K Peterson; Jan Verhoef
Phagocytic and chemotactic function of polymorphonuclear and mononuclear leucocytes in patients with recurrent staphylococcal infections.
Scandinavian journal of infectious diseases 1980;12(2):111-6.
1979: Henri A Verbrugh; W C van Dijk; M E van Erne; R Peters; P K Peterson; Jan Verhoef
Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.
Infection and immunity 1979;26(3):808-14.
1979: D J Schmeling; P K Peterson; D E Hammerschmidt; Y Kim; Jan Verhoef; B J Wilkinson; P G Quie
Chemotaxigenesis by cell surface components of Staphylococcus aureus.
Infection and immunity 1979;26(1):57-63.
1979: W C Van Dijk; Henri A Verbrugh; M E van der Tol; R Peters; Jan Verhoef
Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
Infection and immunity 1979;25(2):603-9.
1979: Henri A Verbrugh; W C Van Dijk; R Peters; M E Van Der Tol; Jan Verhoef
The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
Immunology 1979;37(3):615-21.
1979: Henri A Verbrugh; W C Van Dijk; R Peters; M E Van Der Tol; P K Peterson; Jan Verhoef
Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Immunology 1979;36(3):391-7.
1979: W C Van Dijk; Henri A Verbrugh; R Peters; M E Van Der Tol; P K Peterson; Jan Verhoef
Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.
Journal of medical microbiology 1979;12(1):123-30.
1979: Jan Verhoef; P K Peterson; Henri A Verbrugh
Host-parasite relationship in staphylococcal infections: the role of the staphylococcal cell wall during the process of phagocytosis.
Antonie van Leeuwenhoek 1979;45(1):49-53.
1979: M Rozenberg-Arska; G T Fabius; M A Beens-Dekkers; S A Duursma; L D Sabath; Jan Verhoef
Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus.
Chemotherapy 1979;25(6):352-5.
1979: D N Williams; P K Peterson; Jan Verhoef; M Laverdiere; L D Sabath
Endocarditis caused by coagulase-negative staphylococci.
Infection 1979;7(1):5-9.
1978: P K Peterson; Y Kim; D Schmeling; M Lindemann; Jan Verhoef; P G Quie
Complement-mediated phagocytosis of Pseudomonas aeruginosa.
The Journal of laboratory and clinical medicine 1978;92(6):883-94.
1978: Jan Verhoef; P K Peterson; D N Williams; M Laverdiere; L D Sabath
Atrio-ventricular shuntinfections and endocarditis due to Staphylococcus epidermidis.
Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 1978;241(1):95-100.
1978: Henri A Verbrugh; R Peters; P K Peterson; Jan Verhoef
Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.
Journal of clinical pathology 1978;31(6):539-45.
1978: P K Peterson; B J Wilkinson; Y Kim; D Schmeling; S D Douglas; P G Quie; Jan Verhoef
The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
The Journal of clinical investigation 1978;61(3):597-609.
1977: G S Giebink; Jan Verhoef; P K Peterson; P G Quie
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
Infection and immunity 1977;18(2):291-7.
1977: P K Peterson; Jan Verhoef; D Schmeling; P G Quie
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.
The Journal of infectious diseases 1977;136(4):502-9.
1977: Jan Verhoef; P K Peterson; P G Quie
Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.
Immunology 1977;33(2):231-9.
1977: Jan Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
Immunology 1977;33(2):191-7.
1977: P K Peterson; Jan Verhoef; L D Sabath; P G Quie
Effect of protein A on staphylococcal opsonization.
Infection and immunity 1977;15(3):760-4.
1977: Jan Verhoef; P K Peterson; P G Quie
Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.
Journal of immunological methods 1977;14(3-4):303-11.
1977: P K Peterson; Jan Verhoef; P G Quie
Influence of temperature on opsonization and phagocytosis of staphylococci.
Infection and immunity 1977;15(1):175-9.
1976: P K Peterson; Jan Verhoef; L D Sabath; P G Quie
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.
Infection and immunity 1976;14(2):496-501.
1973: Jan Verhoef; P L Oe; S Simonian
Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The clearance of antibiotics by the artificial kidney.
Antonie van Leeuwenhoek 1973;39(4):654.
1973: Jan Verhoef; P L Oe; S Simonian
The clearance of antibiotics by the artificial kidney.
Chemotherapy 1973;19(5):272-8.